0001193125-22-151154.txt : 20220516 0001193125-22-151154.hdr.sgml : 20220516 20220516111752 ACCESSION NUMBER: 0001193125-22-151154 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Prime Impact Acquisition I CENTRAL INDEX KEY: 0001819175 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39501 FILM NUMBER: 22926657 BUSINESS ADDRESS: STREET 1: 123 E SAN CARLOS STREET STREET 2: SUITE 12 CITY: SAN JOSE STATE: CA ZIP: 95112 BUSINESS PHONE: 650-825-6965 MAIL ADDRESS: STREET 1: 123 E SAN CARLOS STREET STREET 2: SUITE 12 CITY: SAN JOSE STATE: CA ZIP: 95112 10-Q 1 d352893d10q.htm 10-Q 10-Q
falseQ1--12-310001819175CAP10D 0001819175 2022-01-01 2022-03-31 0001819175 2021-12-31 0001819175 2022-03-31 0001819175 2021-01-01 2021-03-31 0001819175 2021-10-24 2021-10-24 0001819175 2021-01-01 2021-12-31 0001819175 2020-12-31 0001819175 2021-03-31 0001819175 us-gaap:CommonClassBMember 2022-03-31 0001819175 us-gaap:CommonClassAMember 2022-03-31 0001819175 srt:MinimumMember 2022-03-31 0001819175 srt:MaximumMember 2022-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember piai:PrimeImpactCaymanLlcMember 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember 2022-03-31 0001819175 us-gaap:IPOMember us-gaap:CommonClassAMember 2022-03-31 0001819175 us-gaap:PrivatePlacementMember 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassBMember piai:FounderSharesMember 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassBMember piai:FounderSharesMember srt:MinimumMember piai:RestrictionOfShareTransferByFoundersPostBusinessCombinationMember 2022-03-31 0001819175 piai:ConditionForTransferOfFounderSharesPostBusinessCombinationMember us-gaap:CommonClassAMember srt:MinimumMember 2022-03-31 0001819175 piai:WorkingCapitalLoanConvertibleIntoWarrantsMember piai:PrimeImpactCaymanLlcAndAffiliatesMember 2022-03-31 0001819175 piai:UnderwritingAgreementMember 2022-03-31 0001819175 piai:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2022-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001819175 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-03-31 0001819175 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-03-31 0001819175 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001819175 piai:PublicWarrantsMember 2022-03-31 0001819175 piai:MarketValueOneMember 2022-03-31 0001819175 piai:MarketValueTwoMember 2022-03-31 0001819175 piai:MarketValueThreeMember 2022-03-31 0001819175 piai:MarketValueThreeMember us-gaap:CommonClassAMember 2022-03-31 0001819175 piai:MarketValueTwoMember us-gaap:CommonClassAMember 2022-03-31 0001819175 piai:WarrantLiabilitiesMember piai:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-03-31 0001819175 piai:WarrantLiabilitiesMember piai:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-03-31 0001819175 piai:WarrantLiabilitiesMember piai:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001819175 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember piai:PrivatePlacementWarrantsMember piai:WarrantLiabilitiesMember 2022-03-31 0001819175 piai:WarrantLiabilitiesMember piai:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-03-31 0001819175 piai:WarrantLiabilitiesMember piai:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001819175 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001819175 us-gaap:CommonClassBMember 2021-12-31 0001819175 us-gaap:CommonClassAMember 2021-12-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001819175 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 piai:PrivatePlacementWarrantsMember 2021-12-31 0001819175 piai:WarrantLiabilitiesMember piai:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001819175 piai:WarrantLiabilitiesMember piai:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001819175 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember piai:PublicWarrantsMember piai:WarrantLiabilitiesMember 2021-12-31 0001819175 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember piai:PrivatePlacementWarrantsMember piai:WarrantLiabilitiesMember 2021-12-31 0001819175 piai:WarrantLiabilitiesMember piai:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001819175 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember piai:PrivatePlacementWarrantsMember piai:WarrantLiabilitiesMember 2021-12-31 0001819175 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001819175 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001819175 us-gaap:CapitalUnitsMember 2022-01-01 2022-03-31 0001819175 us-gaap:PrivatePlacementMember piai:PrivatePlacementWarrantsMember piai:PrimeImpactCaymanLlcMember 2022-01-01 2022-03-31 0001819175 piai:InitialPublicOfferIncludingExerciseOfTheOverAllotmentOptionAndPrivatePlacementMember us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember piai:PrimeImpactCaymanLlcMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-01 2022-03-31 0001819175 piai:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember piai:PrimeImpactCaymanLlcMember 2022-01-01 2022-03-31 0001819175 us-gaap:PrivatePlacementMember piai:PrivatePlacementWarrantsMember piai:SponsorsOfficersAndDirectorsMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassBMember piai:FounderSharesMember piai:PrimeImpactCaymanLlcMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassBMember piai:FounderSharesMember piai:JoannaStroberMember 2022-01-01 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassBMember piai:FounderSharesMember srt:MinimumMember piai:RestrictionOfShareTransferByFoundersPostBusinessCombinationMember 2022-01-01 2022-03-31 0001819175 srt:MinimumMember us-gaap:CommonClassAMember piai:ConditionForTransferOfFounderSharesPostBusinessCombinationMember 2022-01-01 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcAndAffiliatesMember piai:AdministrativeServicesAgreementMember piai:SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember 2022-01-01 2022-03-31 0001819175 us-gaap:OperatingExpenseMember piai:AdministrativeServicesAgreementMember piai:PrimeImpactCaymanLlcAndAffiliatesMember piai:SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember 2022-01-01 2022-03-31 0001819175 us-gaap:AccountsPayableAndAccruedLiabilitiesMember piai:AdministrativeServicesAgreementMember piai:PrimeImpactCaymanLlcAndAffiliatesMember piai:SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember 2022-01-01 2022-03-31 0001819175 us-gaap:IPOMember piai:UnderwritingAgreementMember 2022-01-01 2022-03-31 0001819175 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001819175 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember piai:RelatedPartyNoteTrancheOneMember 2022-01-01 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcAndAffiliatesMember piai:AdministrativeServicesAgreementMember piai:SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember us-gaap:OperatingExpenseMember 2021-01-01 2021-03-31 0001819175 piai:SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember piai:PrimeImpactCaymanLlcAndAffiliatesMember piai:AdministrativeServicesAgreementMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2021-01-01 2021-03-31 0001819175 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001819175 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-01-01 2021-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001819175 us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-03-31 0001819175 us-gaap:CommonClassAMember 2021-01-01 2021-03-31 0001819175 us-gaap:CommonClassBMember 2021-01-01 2021-03-31 0001819175 us-gaap:IPOMember us-gaap:CommonClassAMember 2020-09-14 2020-09-14 0001819175 us-gaap:CommonClassAMember 2020-09-14 2020-09-14 0001819175 piai:PrimeImpactCaymanLlcMember piai:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2020-09-14 2020-09-14 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:PrivatePlacementMember piai:PrivatePlacementWarrantsMember 2020-09-14 2020-09-14 0001819175 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-09-14 0001819175 piai:PrimeImpactCaymanLlcMember piai:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2020-09-14 0001819175 piai:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember piai:PrimeImpactCaymanLlcMember 2020-09-14 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:OverAllotmentOptionMember us-gaap:CommonClassAMember 2020-10-02 2020-10-02 0001819175 piai:FounderSharesMember us-gaap:CommonClassBMember piai:PrimeImpactCaymanLlcMember 2020-10-02 2020-10-02 0001819175 us-gaap:OverAllotmentOptionMember piai:UnderwritingAgreementMember 2020-10-02 2020-10-02 0001819175 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-01-01 2021-12-31 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:OverAllotmentOptionMember us-gaap:CommonClassAMember 2021-01-01 2021-12-31 0001819175 us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001819175 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-09-30 0001819175 us-gaap:CommonClassAMember piai:PrimeImpactCaymanLlcMember us-gaap:OverAllotmentOptionMember 2021-09-30 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:PrivatePlacementMember piai:PrivatePlacementWarrantsMember 2020-10-06 2020-10-06 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:PrivatePlacementMember piai:PrivatePlacementWarrantsMember 2020-10-06 2020-10-06 0001819175 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember piai:PrimeImpactCaymanLlcMember 2020-10-02 0001819175 us-gaap:OverAllotmentOptionMember piai:UnderwritingAgreementMember 2020-10-02 0001819175 us-gaap:WarrantMember 2022-05-11 0001819175 us-gaap:CommonClassBMember 2022-05-11 0001819175 us-gaap:CommonClassAMember 2022-05-11 0001819175 us-gaap:RetainedEarningsMember 2021-12-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001819175 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001819175 us-gaap:RetainedEarningsMember 2022-03-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001819175 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-03-31 0001819175 us-gaap:RetainedEarningsMember 2020-12-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001819175 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-12-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001819175 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001819175 us-gaap:FairValueInputsLevel3Member 2021-03-31 0001819175 us-gaap:RetainedEarningsMember 2021-03-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001819175 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 iso4217:USD xbrli:shares utr:Day xbrli:pure utr:Month utr:Year iso4217:USD xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2022
or
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                
to
                
Commission File
No. 001-39501
 
 
Prime Impact Acquisition I
(Exact name of registrant as specified in its charter)
 
 
 
Cayman Islands
  
98-1554335
(State or other jurisdiction of incorporation)
  
(IRS Employer Identification No.)
   
123 E San Carlos Street, Suite 12
San Jose, California
  
95112
(Address of principal executive offices)
  
(Zip Code)
(650)
825-6965
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Symbol(s)
  
Trading
  
Name of each exchange
on which registered
Units, each consisting of one Class A ordinary share
and one-third of
a Warrant to acquire one Class A ordinary share
  
PIAI.U
  
The New York Stock Exchange
Class A ordinary shares, par value $0.0001 per share
  
PIAI
  
The New York Stock Exchange
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
  
PIAI.W
  
The New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
       
Non-accelerated filer
   ☒    Smaller reporting company   ☒
       
         Emerging growth company   ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☒    No  ☐
As of May 11, 2022, there were 3,336,682 units, each unit consisting of one Class A ordinary share, par value $0.0001 per share, and one third of a warrant to acquire one Class A ordinary share, 
29,071,732
 Class A ordinary shares, 
8,102,103
 Class B ordinary shares, par value $0.0001 per share, and
 
15,411,670
 warrants, were issued and outstanding, respectively. 
 
 
 
PRIME IMPACT ACQUISITION I
Quarterly Report on
Form 10-Q
Table of Contents
 
 
  
 
  
Page No.
 
  
Item 1.
  
  
 
2
 
  
  
 
2
 
  
  
 
3
 
  
  
 
4
 
  
  
 
5
 
  
  
 
6
 
Item 2.
  
  
 
21
 
Item 3.
  
  
 
25
 
Item 4.
  
  
 
25
 
  
Item 1.
  
  
 
26
 
Item 1A.
  
  
 
26
 
Item 2.
  
  
 
26
 
Item 3.
  
  
 
26
 
Item 4.
  
  
 
26
 
Item 5.
  
  
 
26
 
Item 6.
  
  
 
26
 
  
 
28
 
 
1
PART I - FINANCIAL INFORMATION
Item 1. Condensed Financial Statements.
PRIME IMPACT ACQUISITION I
CONDENSED BALANCE SHEETS
 
    
March 31, 2022
    
December 31, 2021
  
    
(unaudited)
        
Assets
                 
Current assets:
                 
Cash
    $ 626,428     $ 665,940  
Prepaid expenses
      73,750       110,626  
    
 
 
    
 
 
  
Total current assets
      700,178       776,566  
Investments held in Trust Account
      324,242,004       324,211,180  
    
 
 
    
 
 
  
Total Assets
   
$
324,942,182
 
  
$
324,987,746
 
    
 
 
    
 
 
  
Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders’ Deficit
                 
Current liabilities:
                 
Accounts payable
    $ 488,099     $ 327,477  
Accrued expenses
      215,936       159,535  
    
 
 
    
 
 
  
Total current liabilities
      704,035       487,012  
Derivative warrant liabilities
      3,965,742       8,922,920  
Deferred underwriting commissions
      11,342,945       11,342,945  
    
 
 
    
 
 
  
Total Liabilities
      16,012,722       20,752,877  
     
Commitments and Contingencies
             
     
Class A ordinary shares subject to possible redemption, $0.0001 par value; 32,408,414 shares issued and outstanding at $10.00 per share at redemption as of March 31, 2022 and December 31, 2021
      324,142,004       324,084,140  
     
Shareholders’ Deficit:
                 
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding
      —         —    
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; no
non-redeemable
shares issued or outstanding
      —         —    
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,102,103 shares issued and outstanding as of March 31, 2022 and December 31, 2021
      810       810  
Additional
paid-in
capital
      —         —    
Accumulated deficit
      (15,213,354 )      (19,850,081 ) 
    
 
 
    
 
 
  
Total Shareholders’ Deficit
      (15,212,544 )      (19,849,271 ) 
    
 
 
    
 
 
  
Total Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders’ Deficit
   
$
324,942,182
 
  
$
324,987,746
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
2
PRIME IMPACT ACQUISITION I
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS
 
    
For the Three Months Ended March 31,
  
    
2022
    
2021
  
General and administrative expenses
    $ 263,428     $ 491,586  
Administrative expenses - related party
      30,000       30,000  
    
 
 
    
 
 
  
Loss from operations
      (293,428 )      (521,586 ) 
     
Other income (expense)
                 
Change in fair value of derivative warrant liabilities
      4,957,178       12,018,044  
Interest income
      17       46  
Income from investments held in Trust Account
      30,824       17,733  
    
 
 
    
 
 
  
Net income
   
$
4,694,591
 
  
$
11,514,237
 
Deemed dividend - increase in redemption value of Class A ordinary shares subject to redemption
      (57,864 )      —    
    
 
 
    
 
 
  
Net income available to ordinary shareholders
   
$
4,636,727
 
  
$
11,514,237
 
    
 
 
    
 
 
  
Weighted average Class A ordinary shares outstanding, basic and diluted
      32,408,414       32,408,414  
    
 
 
    
 
 
  
Basic and diluted net income per Class A ordinary share
    $ 0.11     $ 0.28  
    
 
 
    
 
 
  
Weighted average Class B ordinary shares outstanding, basic and diluted
      8,102,103       8,102,103  
    
 
 
    
 
 
  
Basic and diluted net income per Class B ordinary share
    $ 0.11     $ 0.28  
    
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
3
PRIME IMPACT ACQUISITION I
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE THREE MONTHS ENDED MARCH 31, 2022
 
    
Ordinary Shares
     
Additional
           
Total
  
    
Class A
     
Class B
     
Paid-in
     
Accumulated
    
Shareholders’
  
    
Shares
     
Amount
     
Shares
     
Amount
     
Capital
     
Deficit
    
Deficit
  
Balance - December 31, 2021
   
 
—  
 
   
$
—  
 
   
 
8,102,103
 
   
$
810
 
   
$
—  
 
   
$
(19,850,081
) 
  
$
(19,849,271
) 
Net income
      —          —          —          —          —          4,694,591       4,694,591  
Deemed dividend - increase in redemption value of Class A ordinary shares subject to redemption
      —          —          —          —          —          (57,864 )      (57,864 ) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance - March 31, 2022
   
 
—  
 
   
$
—  
 
   
 
8,102,103
 
   
$
810
 
   
$
—  
 
   
$
(15,213,354
) 
  
$
(15,212,544
) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
FOR THE THREE MONTHS ENDED MARCH 31, 2021
 
    
Ordinary Shares
     
Additional
           
Total
  
    
Class A
     
Class B
     
Paid-in
     
Accumulated
    
Shareholders’
  
    
Shares
     
Amount
     
Shares
     
Amount
     
Capital
     
Deficit
    
Deficit
  
Balance - December 31, 2020
   
 
—  
 
   
$
—  
 
   
 
8,102,103
 
   
$
810
 
   
$
—  
 
   
$
(35,618,082
) 
  
$
(35,617,272
) 
Net income
      —          —          —          —          —          11,514,237       11,514,237  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance - March 31, 2021
   
 
—  
 
   
$
—  
 
   
 
8,102,103
 
   
$
810
 
   
$
—  
 
   
$
(24,103,845
) 
  
$
(24,103,035
) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
4
PRIME IMPACT ACQUISITION I
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
 
    
For the Three Months Ended March 31,
  
    
2022
    
2021
  
Cash Flows from Operating Activities:
                 
Net income
    $ 4,694,591     $ 11,514,237  
Adjustments to reconcile net income to net cash used in operating activities:
                 
Change in fair value of derivative warrant liabilities
      (4,957,178 )      (12,018,044 ) 
Income from investments held in Trust Account
      (30,824 )      (17,733 ) 
Changes in operating assets and liabilities:
                 
Prepaid expenses
      36,876       73,098  
Accounts payable
      160,622       369,533  
Accrued expenses
      56,401       30,000  
    
 
 
    
 
 
  
Net cash used in operating activities
      (39,512 )      (48,909 ) 
    
 
 
    
 
 
  
Net change in cash
      (39,512 )      (48,909 ) 
     
Cash - beginning of the period
      665,940       1,600,255  
    
 
 
    
 
 
  
Cash - end of the period
   
$
626,428
 
  
$
1,551,346
 
    
 
 
    
 
 
  
Supplemental disclosure of noncash investing and financing activities:
                 
Remeasurement on Class A ordinary shares subject to possible redemption
    $ (57,864 )    $ —    
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
5
PRIME IMPACT ACQUISITION I
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Note 1 — Description of Organization and Business Operations
Prime Impact Acquisition I (the “Company”) was incorporated as a Cayman Islands exempted company on July 21, 2020. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
As of March 31, 2022, the Company had not commenced any operations. All activity for the period from July 21, 2020 (inception) through March 31, 2022 relates to the Company’s formation and the preparation of the initial public offering described below (the “Initial Public Offering”), and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering.
The Company’s sponsor is Prime Impact Cayman, LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Initial Public Offering was declared effective on September 9, 2020. On September 14, 2020, the Company consummated the Initial Public Offering of 30,000,000 units (each, a “Unit” and collectively, the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, inclusive of approximately $10.5 million in deferred underwriting commissions (Note 6). The underwriters were granted a
45-day
option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On October 2, 2020, the underwriters partially exercised the over-allotment option to purchase an additional 2,408,414 units (the “Over-Allotment Units”). On October 6, 2020, the Company completed the sale of the Over-Allotment Units to the underwriters (the “Over-Allotment”), generating gross proceeds of approximately $24.1 million, and incurring additional offering costs of approximately $1.3 million in underwriting fees (inclusive of approximately $0.8 million in deferred underwriting commissions).
Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 5,400,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $8.1 million (Note 4). Simultaneously with the closing of the Over-Allotment Units, on October 6, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an additional 321,122 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $0.5 million.
Upon the closing of the Initial Public Offering and the Private Placement, $324.1 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering, the Over-Allotment and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and was invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule
2a-7
promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount) at the time the Company signs a definitive
 
6
agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
The Company will provide its holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The
per-share
amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which will be adopted by the Company upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares (as defined in Note 5) prior to this Initial Public Offering (the “Initial Shareholders”) have agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company has agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor.
Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.
The Company’s Sponsor, executive officers, directors and director nominees have agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.
If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or September 14, 2022 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay
 
7
dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.
In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses).
The Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Note 2 — Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 10 of Regulation
S-X.
Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these condensed financial statements as they are not required for interim financial statements under GAAP and the rules of the Securities and Exchange Commission. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form
10-K
for the year ended December 31, 2021, as filed with the SEC on March 21, 2022, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2021, is derived from the audited financial statements presented in the Company’s Annual Report on
Form 10-K
for the year ended December 31, 2021, as filed with the SEC on March 21, 2022.
 
8
Liquidity and Going Concern
As of March 31, 2022, the Company had approximately $0.6
 million in its operating bank account and working capital deficit of approximately $
4,000.
Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through the payment of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of approximately $98,000 pursuant to the Note (as defined in Note 5) issued to the Sponsor (Note 5). The Company repaid the Note in full on September 16, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of March 31, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loans.
The Company’s management plans to continue its efforts to complete a Business Combination within 24 months of the closing of the Initial Public Offering, or September 14, 2022. The Company believes that the funds currently available to it outside of the Trust Account will be sufficient to allow it to operate until September 14, 2022; however, there can be no assurances that this estimate is accurate.
In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic
205-40,
“Presentation of Financial Statements - Going Concern,” management has determined that the liquidity concerns, mandatory liquidation date and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to complete a business combination by September 14, 2022, then the Company will cease all operations except for the purpose of liquidating. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September 14, 2022.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
 
9
Use of Estimates
The preparation of these condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2022 and December 31, 2021, there were no cash equivalents held outside of the Trust Account.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of March 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” approximates the carrying amounts represented in the condensed balance sheets, other than investments held in Trust Account and derivative warrant liabilities, both of which are described below.
Investments Held in Trust Account
The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof.
When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. 
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
10
  •  
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period. Derivative warrant liabilities are classified as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statements of operations. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants.
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of the FASB ASC Topic
340-10-S99-1
and SEC Staff Accounting Bulletin Topic 5A—“Expenses of Offering.” Offering costs consisted of legal, accounting, underwriting commissions and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Public Shares were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, an aggregate of 32,408,414 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.
 
11
Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional
paid-in
capital (to the extent available) and accumulated deficit.
Income Taxes
FASB ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income, adjusted for the effects of a deemed dividend to Class A shareholders, by the weighted average ordinary shares outstanding for the respective period.
The calculation of diluted net income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of 
16,523,926
 ordinary shares in the calculation of diluted income per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the three months ended March 31, 2022 and 2021. The initial accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. Subsequent periods accretion of Class A ordinary shares subject to possible redemption is recognized as a deemed dividend to shareholders in the calculation of the net income per ordinary share. 
The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary share:
 
    
For the Three Months Ended March 31,
  
    
2022
     
2021
  
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income per ordinary share:
                                    
Numerator:
                                    
Allocation of net income available to ordinary shareholders
    $ 3,709,382      $ 927,345      $ 9,211,390      $ 2,302,847  
         
Denominator:
                                    
Basic and diluted weighted average ordinary shares outstanding
      32,408,414        8,102,103        32,408,414        8,102,103  
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income per common share
    $ 0.11      $ 0.11      $ 0.28      $ 0.28  
    
 
 
     
 
 
     
 
 
     
 
 
  
 
12
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
Note
3-Initial
Public Offering
On September 14, 2020, the Company consummated the Initial Public Offering of 30,000,000 units, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, inclusive of approximately $10.5 million in deferred underwriting commissions. The underwriters were granted a
45-day
option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On October 2, 2020, the underwriters partially exercised the Over-Allotment option to purchase an additional 2,408,414 units and on October 6, 2020, the Company completed the sale of the Over-Allotment Units to the underwriters, generating gross proceeds of approximately $24.1 million, and incurring additional offering costs of approximately $1.3 million in underwriting fees (inclusive of approximately $0.8 million in deferred underwriting commissions).
Each Unit consists of one Class A ordinary share and
one-third
of one redeemable warrant. Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7).
Note
4-Private
Placement
Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement with the purchase of 5,400,000 Private Placement Warrants by the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $8.1 million. Simultaneously with the closing of the Over-Allotment Units, on October 6, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 321,122 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $0.5 million.
Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be
non-redeemable
for cash and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.
The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.
Note
5-Related
Party Transactions
Founder Shares
On July 23, 2020, the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 8,625,000 Class B ordinary shares (the “Founder Shares”). The holders of the Founder Shares agreed to forfeit up to an aggregate of 1,125,000 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional units was not exercised in full by the underwriters, so that the Founder Shares would represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On September 3, 2020, the Sponsor transferred 20,000 Founder Shares to each of Cathleen Benko, Roger Crockett, Dixon Doll, Keyur Patel and Joanna Strober. Such Founder Shares are not subject to forfeiture in the event the underwriters’ Over-Allotment was not exercised. On October 2, 2020, the underwriters partially exercised the Over-Allotment option to purchase as additional 2,408,414 Units. On October 24, 2020 (the 45th day follow the Underwriting Agreement), 522,897 Class B ordinary shares were forfeited.
 
13
The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share
sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Sponsor and the Company’s founding team with respect to any Founder Shares, Private Placement Warrants and Class A ordinary shares issued upon conversion or exercise thereof. Notwithstanding the foregoing, if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share
sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the
lock-up.
Related Party Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.
The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.
Administrative Services Agreement
The Company entered into an agreement that provided that, commencing on the date that the Company’s securities are first listed on the New York Stock Exchange through the earlier of consummation of the initial Business Combination or the Company’s liquidation, the Company will pay the Sponsor $10,000 per month for office space, secretarial and administrative services. The Company incurred $30,000 and $30,000
 in expenses in connection with such services during the three months ended March 31, 2022 and 2021, respectively, as reflected in the administrative expenses—related party on the accompanying unaudited condensed statements of operations. As of March 31, 2022 and December 31, 2021, the Company had $
185,000 and $155,000, respectively, in accrued expenses in connection with such services as reflected in the accompanying condensed balance sheets.
In addition, the Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any
out-of-pocket
expenses incurred in connection with activities on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, executive officers or directors of the Company’s or their affiliates. Any such payments prior to an initial Business Combination will be made using of funds held outside the Trust Account.
 
14
Note
6-Commitments
and Contingencies
Risk and Uncertainties
On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the
“COVID-19
outbreak”). In March 2020, the WHO classified the
COVID-19
outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the
COVID-19
outbreak continues to evolve. The impact of the
COVID-19
outbreak on the Company’s results of operations, financial position and cash flows will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the
COVID-19
outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s results of operations, financial position and cash flows may be materially adversely affected. Additionally, the Company’s ability to complete an initial Business Combination may be materially adversely affected due to significant governmental measures being implemented to contain the
COVID-19
outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial Business Combination in a timely manner. The Company’s ability to consummate an Initial Business Combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the
COVID-19
outbreak and the resulting market downturn.
Registration and Shareholder Rights
The holders of the Founder Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration and shareholder rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters a
45-day
option from the date of the prospectus to purchase up to 4,500,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On October 2, 2020, the underwriters partially exercised the Over-allotment option to purchase an additional 2,408,414 Units.
The underwriters were entitled to an underwriting discount of $0.20 per Unit, or $6.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $10.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
If the option to purchase additional units was exercised in full, the underwriters would have been entitled to an aggregate of $900,000 in fees payable upon closing and additional deferred underwriting commissions of approximately $1.6 million. On October 2, 2020, the Over-Allotment option was partially exercised, resulting in an underwriting discount of approximately $0.5 million deducted from the proceeds received for sale of the Over-Allotment Units, and approximately $0.8 million of deferred underwriting commissions.
Note
7-Derivative
Warrant Liabilities
As of March 31, 2022 and December 31, 2021, the Company had an aggregate of 16,523,926 warrants outstanding, comprised of 10,802,804 Public Warrants and 5,721,122 Private Warrants.
Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the
 
15
Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the “Newly Issued Price,” (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and 18.00 per share redemption trigger prices described below under “Redemption of warrants when the price per Class A ordinary share equal or exceed $10.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be
non-redeemable
so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the Initial Shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants):
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
 
16
  •  
if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share
sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”).
Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants:
 
  •  
in whole and not in part;
 
  •  
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares;
 
  •  
if, and only if, the Reference Value equals or exceeds $10.00 per Public Share (as adjusted per share
sub-divisions,
share dividends, reorganizations, recapitalizations and the like); and
 
  •  
if the Reference Value is less than $18.00 per share (as adjusted for share
sub-divisions,
share dividends, rights issuances,
sub-divisions,
reorganizations, recapitalizations and the like), then the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants as described above.
The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the
30-day
redemption period. Any such exercise would not be on a “cashless” basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised.
The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume-weighted average price of the Class A ordinary shares for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment).
If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
Note
8-Class
A Ordinary Shares Subject to Possible Redemption
The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 200,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. As of March 31, 2022 and December 31, 2021, there were 32,408,414 Class A ordinary shares outstanding, which were all subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets.
 
17
The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets are reconciled on the following table:
 
    
March 31, 2022
     
December 31, 2021
  
Gross proceeds
    $ 324,084,140      $ 324,084,140  
Less:
                  
Amount allocated to Public Warrants
      (12,955,337 )       (12,955,337 ) 
Class A ordinary shares issuance costs
      (17,680,825 )       (17,680,825 ) 
Plus:
                  
Accretion of carrying value to redemption value
      30,694,026        30,636,162  
    
 
 
     
 
 
  
Class A ordinary shares subject to possible redemption
    $ 324,142,004      $ 324,084,140  
    
 
 
     
 
 
  
Note
9-Shareholders’
Deficit
Preference Shares-
The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share. As of March 31, 2022 and December 31, 2021, there were no preference shares issued or outstanding.
Class
 A Ordinary Shares-
The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of March 31, 2022 and December 31, 2021, there were 32,408,414 Class A ordinary shares issued and outstanding, all of which are subject to possible redemption and therefore classified as temporary equity in the accompanying condensed balance sheets (see Note 8).
Class
 B Ordinary Shares-
The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of March 31, 2022 and December 31, 2021, 8,102,103 Class B ordinary shares were issued and outstanding. Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law.
The Class B ordinary shares will automatically convert into Class A ordinary shares immediately upon the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an
as-converted
basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, members of the Company’s founding team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.
 
18
Note
10-Fair
Value Measurements
The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021 by level within the fair value hierarchy:
 
    
As of March 31, 2022
  
Description
   
Quoted Prices
in Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Assets:
                           
Investments held in Trust Account
    $ 324,242,004      $ —        $ —    
Liabilities:
                           
Derivative warrant liabilities-Public warrants
    $ 2,592,673      $ —        $ —    
Derivative warrant liabilities-Private placement warrants
    $ —        $ —        $ 1,373,069  
 
    
As of December 31, 2021
  
Description
   
Quoted Prices
in Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Assets:
                           
Investments held in Trust Account
    $ 324,211,180      $ —        $ —    
Liabilities:
                           
Derivative warrant liabilities-Public warrants
    $ 5,833,514      $ —        $ —    
Derivative warrant liabilities-Private placement warrants
    $ —        $ —        $ 3,089,406  
Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There were no transfers between levels of the hierarchy during the three-month periods ending March 31, 2022 and 2021.
Level 1 assets include investments in U.S. Treasury securities or money market funds that invest solely in U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value.
The fair value of the Public Warrants is measured based on the listed market price of such warrants, a Level 1 measurement. The estimated fair value of the Private Placement Warrant is based on a Monte Carlo simulation, which includes use of some Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its Class A ordinary shares warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s Class A ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury
zero-coupon
yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.
The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:
 
    
March 31,
2022
    
December 31,
2021
  
Exercise price
    $ 11.50     $ 11.50  
Stock price
    $ 9.89     $ 9.84  
Volatility
      3.6 %      9.3 % 
Term
      5.46       5.58  
Risk-free rate
      2.39 %      1.30 % 
Dividend yield
      0.0 %      0.0 % 
 
19
The change in the fair value of the derivative warrant liabilities measured with Level 3 inputs for the three months ended March 31, 2022 and March 31, 2021 is summarized as follows:
 
    
2022
     
2021
  
Level 3 derivative warrant liabilities at January 1,
    $ 3,089,406      $ 9,096,584  
Change in fair value of derivative warrant liabilities
      (1,716,337 )       (4,348,053 ) 
    
 
 
     
 
 
  
Level 3 derivative warrant liabilities at March 31,
    $ 1,373,069      $ 4,748,531  
    
 
 
     
 
 
  
Note 10 — Subsequent Events
On April 28, 2022, Cathleen Benko resigned from the Company’s board of directors. Keyur Patel was appointed to the audit committee to fill the vacancy created by Ms. Benko’s resignation.
The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.
 
20
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
References to the “Company,” “Prime Impact Acquisition I,” “Prime Impact,” “our,” “us” or “we” refer to Prime Impact Acquisition I. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form
10-Q
includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Exchange Act of 1934 (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other U.S. Securities and Exchange Commission (the “SEC”) filings.
Overview
We are a blank check company incorporated as a Cayman Islands exempted company on July 21, 2020. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.
Our sponsor is Prime Impact Cayman, LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the initial public offering was declared effective on September 9, 2020 (the “Initial Public Offering”). On September 14, 2020, we consummated the Initial Public Offering of 30,000,000 units (each, a “Unit” and collectively, the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, inclusive of approximately $10.5 million in deferred underwriting commissions. The underwriters were granted a
45-day
option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On October 2, 2020, the underwriters partially exercised the over-allotment option to purchase an additional 2,408,414 units (the “Over-Allotment Units”). On October 6, 2020, we completed the sale of the Over-Allotment Units to the underwriters (the “Over-Allotment”), generating gross proceeds of approximately $24.1 million, and incurring additional offering costs of approximately $1.3 million in underwriting fees (inclusive of approximately $0.8 million in deferred underwriting commissions).
Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 5,400,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to us of $8.1 million. Simultaneously with the closing of the Over-allotment Units, on October 6, 2020, we consummated the second closing of the Private Placement, resulting in the purchase of an additional 321,122 Private Placement Warrants by the Sponsor, generating gross proceeds to us of approximately $0.5 million.
Upon the closing of the Initial Public Offering and the Private Placement, $324.1 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering, the Over-Allotment and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and was invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule
2a-7
promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
 
21
Our management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Our initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount) at the time we sign a definitive agreement in connection with the initial Business Combination. However, we will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
If we are unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or September 14, 2022 (the “Combination Period”), we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.
Liquidity and Going Concern
As of March 31, 2022, we had approximately $0.6 million in our operating bank account and working capital deficit of approximately $4,000.
Prior to the completion of the Initial Public Offering, our liquidity needs had been satisfied through the payment of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of Class B ordinary shares and a loan of approximately $98,000 pursuant to a promissory note issued to the Sponsor. We repaid the promissory note in full on September 16, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, our liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, provide us Working Capital Loans. As of March 31, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loans.
In connection with our assessment of going concern considerations in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic
205-40,
“Presentation of Financial Statements—Going Concern,” our management has determined that the mandatory liquidation date and subsequent dissolution raises substantial doubt about our ability to continue as a going concern. If we are unable to complete a business combination within 24 months of the closing of the Initial Public Offering, or September 14, 2022, then we will cease all operations except for the purpose of liquidating. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after September 14, 2022. Our management plans to continue its efforts to complete a Business Combination by September 14, 2022. We believe that the funds currently available to us outside of the Trust Account will be sufficient to allow us to operate until September 14, 2022; however, there can be no assurances that this estimate is accurate.
Management continues to evaluate the impact of the
COVID-19
pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on our financial position, results of our operations and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Results of Operations
Our entire activity since inception through March 31, 2022, related to our formation, the preparation for the Initial Public Offering, and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. We have neither engaged in any operations nor generated any revenues to date. We will not generate any operating revenues until after completion of our initial Business Combination. We
generated non-operating
income in the form of investment income from the investments held in the Trust Account following the closing of the Initial Public Offering.
 
22
For the three months ended March 31, 2022, we had a net income of approximately $4.7 million, which consisted of a
non-operating
gain of approximately $5.0 million from the change in fair value of derivative warrant liabilities and approximately $31,000 in interest income from investments held in the Trust Account, partially offset by approximately $263,000 in general and administrative expenses and $30,000 in administrative expenses – related party.
For the three months ended March 31, 2021, we had net income of approximately $11.5 million, which consisted of a
non-operating
gain of approximately $12.0 million from the change in fair value of derivative warrant liabilities and approximately $18,000 in interest income from investments held in Trust account, partially offset by approximately $492,000 in general and administrative expenses and $30,000 in administrative expenses – related party.
Contractual Obligations
We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities.
We entered into an administrative services agreement pursuant to which we have agreed to pay our Sponsor a total of $10,000 per month for office space, utilities and administrative support. Upon completion of the Initial Business Combination or our liquidation, the agreement will terminate.
The underwriters of the Initial Public Offering were entitled to underwriting discounts and commissions of 5.5%, of which 2.0% (approximately $6.5 million) was paid at the closing of the Initial Public Offering and closing of sale of the Over-Allotment Units and 3.5% (approximately $11.3 million) was deferred. The deferred underwriting discounts and commissions will become payable to the underwriters upon the consummation of the Initial Business Combination and will be paid from the amounts held in the Trust Account. The underwriters are not entitled to any interest accrued on the deferred underwriting discounts and commissions.
Critical Accounting Policies
The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. A summary of our significant accounting policies is included in Note 2 to our condensed financial statements in Part I, Item 1 of this Quarterly Report. Certain of our accounting policies are considered critical, as these policies are the most important to the depiction of our condensed financial statements and require significant, difficult or complex judgments, often employing the use of estimates about the effects of matters that are inherently uncertain. Such policies are summarized in the Management’s Discussion and Analysis of Financial Condition and Results of Operations section in our 2021 Annual Report on Form
10-K
filed with the SEC on March 21, 2022. There have been no significant changes in the application of our critical accounting policies during the three months ended March 31, 2022.
Recent Accounting Pronouncements
See Note 2 to the unaudited condensed financial statements included in Part I, Item 1 of this Quarterly Report for a discussion of recent accounting pronouncements.
JOBS Act
The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for
non-emerging
growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404,
 
23
(ii) provide all of the compensation disclosure that may be required of
non-emerging
growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the Chief Executive Officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.
 
24
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by
Rule 12b-2 of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are not required to provide the information otherwise required under this item.
 
Item 4.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31, 2022, as such term is defined in Rules
13a-15(e)
and
15d-15(e)
under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer has concluded that during the period covered by this report, our disclosure controls and procedures were not effective as of March 31, 2022, because of a material weakness in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Specifically, the Company’s management has concluded that our internal controls around the interpretation and accounting for certain equity and equity-linked instruments issued by the Company was not effectively designed or maintained. This material weakness resulted in the restatement of the Company’s balance sheet as of September 14, 2020, its annual financial statements for the period ended December 31, 2020 and its interim financial statements for the quarters ended September 30, 2020, March 31, 2021 and June 30, 2021. Additionally, this material weakness could result in a misstatement of the carrying value of equity, equity-linked instruments and related accounts and disclosures that would result in a material misstatement of the financial statements that would not be prevented or detected on a timely basis. As a result, our management performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with generally accepted in the United States of America. Accordingly, management believes that the financial statements included in this Quarterly Report on Form
10-Q
present fairly, in all material respects, our financial position, result of operations and cash flows of the periods presented. Management understands that the accounting standards applicable to our financial statements are complex and has since the inception of the Company benefited from the support of experienced third-party professionals with whom management has regularly consulted with respect to accounting issues. Management intends to continue to further consult with such professionals in connection with accounting matters.
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our chief executive officer and chief financial officer, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended March 31, 2022 covered by this Quarterly Report on Form
10-Q
that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Our principal executive officer and principal financial officer performed additional accounting and financial analyses and other post-closing procedures including consulting with subject matter experts related to the accounting for certain equity and equity-linked financial instruments. The Company’s management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation and improvement of our internal control over financial reporting. While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we have expanded and will continue to improve these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards.
 
25
PART II – OTHER INFORMATION
 
Item 1.
Legal Proceedings
None
 
Item 1A.
Risk Factors.
Our material risk factors are disclosed in “Risk Factors” in Part I, Item 1A of our Annual Report on Form
10-K.
There have been no material changes from the risk factors previously disclosed in such filing.
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities
None.
 
Item 3.
Defaults Upon Senior Securities
None.
 
Item 4.
Mine Safety Disclosures
Not applicable.
 
Item 5.
Other Information
None.
 
Item 6.
Exhibits
 
26
Exhibit
Number
   
Description
31.1*    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS    XBRL Instance Document
101.SCH    XBRL Taxonomy Extension Schema Document
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document
101.LAB    XBRL Taxonomy Extension Label Linkbase Document
101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
 
*
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
 
27
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: May 16, 2022   
PRIME IMPACT ACQUISITION I
   By:   
/s/ Michael Cordano
   Name:    Michael Cordano
   Title:   
Co-Chief
Executive Officer
      (Principal Executive Officer)
   By:   
/s/ Mark Long
   Name:    Mark Long
   Title:   
Co-Chief
Executive Officer and Chief Financial Officer
      (Principal Financial and Accounting Officer)
 
28
EX-31.1 2 d352893dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE

ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael Cordano, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Prime Impact Acquisition I;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) (Paragraph omitted pursuant to SEC release Nos. 33-8238/34-47986 and 33-8392/34-49313);

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 16, 2022     By:  

/s/ Michael Cordano

    Name:   Michael Cordano
    Title:  

Co-Chief Executive Officer

(Principal Executive Officer)

 

 EX-31.2 3 d352893dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE

ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark Long, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Prime Impact Acquisition I;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) (Paragraph omitted pursuant to SEC release Nos. 33-8238/34-47986 and 33-8392/34-49313);

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 16, 2022     By:  

/s/ Mark Long

    Name:   Mark Long
    Title:   Co-Chief Executive Officer and Chief Financial Officer
      (Principal Financial and Accounting Officer)

 

 EX-32.1 4 d352893dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Prime Impact Acquisition I (the “Company”) on Form 10-Q for the period ending March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Cordano, in my capacity as Co-Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 16, 2022     By:  

/s/ Michael Cordano

    Name:   Michael Cordano
    Title:  

Co-Chief Executive Officer

(Principal Executive Officer)

 EX-32.2 5 d352893dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Prime Impact Acquisition I (the “Company”) on Form 10-Q for the period ending March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Long, in my capacity as Co-Chief Executive Officer and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 16, 2022     By:  

/s/ Mark Long

    Name:   Mark Long
    Title:  

Co-Chief Executive Officer and Chief Financial Officer

(Principal Financial and Accounting Officer)

 EX-101.SCH 6 piai-20220331.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Balance sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Balance sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Statements of Changes in Shareholders' Deficit link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Description of Organization and Business Operations link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Private Placement link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Derivative Warrant Liabilities link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Shareholders' Deficit link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Tables) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Description of Organization and Business Operations - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Basic And Diluted Net Income per Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Initial Public Offering - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Private Placement - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Derivative Warrant Liabilities - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption - Summary of Ordinary shares Subject to Possible Redemption (Detail) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Shareholders' Deficit - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Fair Value Measurements - Summary of Assets that are Measured at Fair Value on a Recurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Fair Value Measurements - Summary of the Table Provides Quantitative Information Regarding Level 3 Fair Value Measurements Inputs at their Measurement Dates (Detail) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Fair Value Measurements - Summary of Change in Fair Value of the Derivative Warrant Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 piai-20220331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 piai-20220331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 piai-20220331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 piai-20220331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover Page - shares
 3 Months Ended
Mar. 31, 2022
May 11, 2022
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Current Fiscal Year End Date --12-31  
Entity Registrant Name Prime Impact Acquisition I  
Entity Central Index Key 0001819175  
Entity Incorporation, State or Country Code E9  
Entity File Number 001-39501  
Entity Tax Identification Number 98-1554335  
Entity Address, Address Line One 123 E San Carlos Street  
Entity Address, Address Line Two Suite 12  
Entity Address, City or Town San Jose  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 95112  
City Area Code 650  
Local Phone Number 825-6965  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company true  
Capital Units [Member]    
Document Information [Line Items]    
Title of 12(b) Security Units, each consisting of one Class A ordinary share and one-third of a Warrant to acquire one Class A ordinary share  
Trading Symbol PIAI.U  
Security Exchange Name NYSE  
Warrant [Member]    
Document Information [Line Items]    
Title of 12(b) Security Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50  
Trading Symbol PIAI.W  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   15,411,670
Common Class A [Member]    
Document Information [Line Items]    
Title of 12(b) Security Class A ordinary shares, par value $0.0001 per share  
Trading Symbol PIAI  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   29,071,732
Common Class B [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   8,102,103
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Balance sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 626,428 $ 665,940
Prepaid expenses 73,750 110,626
Total current assets 700,178 776,566
Investments held in Trust Account 324,242,004 324,211,180
Total Assets 324,942,182 324,987,746
Current liabilities:    
Accounts payable 488,099 327,477
Accrued expenses 215,936 159,535
Total current liabilities 704,035 487,012
Derivative warrant liabilities 3,965,742 8,922,920
Deferred underwriting commissions 11,342,945 11,342,945
Total Liabilities 16,012,722 20,752,877
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value; 32,408,414 shares issued and outstanding at $10.00 per share at redemption as of March 31, 2022 and December 31, 2021 324,142,004 324,084,140
Shareholders' Deficit    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital 0 0
Accumulated deficit (15,213,354) (19,850,081)
Total Shareholders' Deficit (15,212,544) (19,849,271)
Total Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders' Deficit 324,942,182 324,987,746
Common Class A [Member]    
Shareholders' Deficit    
Common stock 0 0
Common Class B [Member]    
Shareholders' Deficit    
Common stock $ 810 $ 810
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Balance sheets (Parenthetical) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Preferred stock par or stated value per share $ 0.0001 $ 0.0001
Preferred stock shares authorized 1,000,000 1,000,000
Preferred stock shares issued 0 0
Preferred stock shares outstanding 0 0
Common Class A [Member]    
Temporary equity redemption price per share $ 10.00 $ 10.00
Temporary equity redemption value per share $ 0.0001 $ 0.0001
Temporary equity shares issued 32,408,414 32,408,414
Temporary equity shares outstanding 32,408,414 32,408,414
Common stock par or stated value per share $ 0.0001 $ 0.0001
Common stock shares authorized 200,000,000 200,000,000
Common stock shares issued 0 0
Common stock shares outstanding 0 0
Common Class B [Member]    
Common stock par or stated value per share $ 0.0001 $ 0.0001
Common stock shares authorized 20,000,000 20,000,000
Common stock shares issued 8,102,103 8,102,103
Common stock shares outstanding 8,102,103 8,102,103
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Statements of Operations - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
General and administrative expenses $ 263,428 $ 491,586
Administrative expenses - related party 30,000 30,000
Loss from operations (293,428) (521,586)
Change in fair value of derivative warrant liabilities 4,957,178 12,018,044
Interest income 17 46
Income from investments held in Trust Account 30,824 17,733
Net income (loss) 4,694,591 11,514,237
Deemed dividend - increase in redemption value of Class A ordinary shares subject to redemption (57,864) 0
Net income attributable 4,636,727 11,514,237
Common Class A [Member]    
Net income attributable $ 3,709,382 $ 9,211,390
Weighted average ordinary shares outstanding, basic and diluted 32,408,414 32,408,414
Basic and diluted net income (loss) per ordinary share $ 0.11 $ 0.28
Common Class B [Member]    
Net income attributable $ 927,345 $ 2,302,847
Weighted average ordinary shares outstanding, basic and diluted 8,102,103 8,102,103
Basic and diluted net income (loss) per ordinary share $ 0.11 $ 0.28
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Statements of Changes in Shareholders' Deficit - USD ($)
Total
Ordinary Shares [Member]
Class A [Member]
Ordinary Shares [Member]
Class B [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Beginning Balance at Dec. 31, 2020 $ (35,617,272) $ 0 $ 810 $ 0 $ (35,618,082)
Beginning Balance, Shares at Dec. 31, 2020   0 8,102,103    
Net income (loss) 11,514,237 $ 0 $ 0 0 11,514,237
Deemed dividend - increase in redemption value of Class A ordinary shares subject to redemption 0        
Ending balance at Mar. 31, 2021 (24,103,035) $ 0 $ 810 0 (24,103,845)
Ending balance, Shares at Mar. 31, 2021   0 8,102,103    
Beginning Balance at Dec. 31, 2021 (19,849,271) $ 0 $ 810 0 (19,850,081)
Beginning Balance, Shares at Dec. 31, 2021   0 8,102,103    
Net income (loss) 4,694,591 $ 0 $ 0 0 4,694,591
Deemed dividend - increase in redemption value of Class A ordinary shares subject to redemption (57,864)       (57,864)
Ending balance at Mar. 31, 2022 $ (15,212,544) $ 0 $ 810 $ 0 $ (15,213,354)
Ending balance, Shares at Mar. 31, 2022   0 8,102,103    
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ 4,694,591 $ 11,514,237
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Change in fair value of derivative warrant liabilities (4,957,178) (12,018,044)
Income from investments held in Trust Account (30,824) (17,733)
Changes in operating assets and liabilities:    
Prepaid expenses 36,876 73,098
Accounts payable 160,622 369,533
Accrued expenses 56,401 30,000
Net cash used in operating activities (39,512) (48,909)
Net change in cash (39,512) (48,909)
Cash - beginning of the period 665,940 1,600,255
Cash - ending of the period 626,428 1,551,346
Supplemental disclosure of noncash investing and financing activities:    
Remeasurement on Class A ordinary shares subject to possible redemption $ (57,864) $ 0
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Description of Organization and Business Operations
 3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Organization and Business Operations
Note 1 — Description of Organization and Business Operations
Prime Impact Acquisition I (the “Company”) was incorporated as a Cayman Islands exempted company on July 21, 2020. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
As of March 31, 2022, the Company had not commenced any operations. All activity for the period from July 21, 2020 (inception) through March 31, 2022 relates to the Company’s formation and the preparation of the initial public offering described below (the “Initial Public Offering”), and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering.
The Company’s sponsor is Prime Impact Cayman, LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Initial Public Offering was declared effective on September 9, 2020. On September 14, 2020, the Company consummated the Initial Public Offering of 30,000,000 units (each, a “Unit” and collectively, the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, inclusive of approximately $10.5 million in deferred underwriting commissions (Note 6). The underwriters were granted a
45-day
option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On October 2, 2020, the underwriters partially exercised the over-allotment option to purchase an additional 2,408,414 units (the “Over-Allotment Units”). On October 6, 2020, the Company completed the sale of the Over-Allotment Units to the underwriters (the “Over-Allotment”), generating gross proceeds of approximately $24.1 million, and incurring additional offering costs of approximately $1.3 million in underwriting fees (inclusive of approximately $0.8 million in deferred underwriting commissions).
Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 5,400,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $8.1 million (Note 4). Simultaneously with the closing of the Over-Allotment Units, on October 6, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an additional 321,122 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $0.5 million.
Upon the closing of the Initial Public Offering and the Private Placement, $324.1 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering, the Over-Allotment and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and was invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule
2a-7
promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount) at the time the Company signs a definitive
 
agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
The Company will provide its holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The
per-share
amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which will be adopted by the Company upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares (as defined in Note 5) prior to this Initial Public Offering (the “Initial Shareholders”) have agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company has agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor.
Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.
The Company’s Sponsor, executive officers, directors and director nominees have agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.
If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or September 14, 2022 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay
 
dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.
In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses).
The Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies
 3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies
Note 2 — Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 10 of Regulation
S-X.
Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these condensed financial statements as they are not required for interim financial statements under GAAP and the rules of the Securities and Exchange Commission. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form
10-K
for the year ended December 31, 2021, as filed with the SEC on March 21, 2022, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2021, is derived from the audited financial statements presented in the Company’s Annual Report on
Form 10-K
for the year ended December 31, 2021, as filed with the SEC on March 21, 2022.
Liquidity and Going Concern
As of March 31, 2022, the Company had approximately $0.6
 million in its operating bank account and working capital deficit of approximately $
4,000.
Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through the payment of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of approximately $98,000 pursuant to the Note (as defined in Note 5) issued to the Sponsor (Note 5). The Company repaid the Note in full on September 16, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of March 31, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loans.
The Company’s management plans to continue its efforts to complete a Business Combination within 24 months of the closing of the Initial Public Offering, or September 14, 2022. The Company believes that the funds currently available to it outside of the Trust Account will be sufficient to allow it to operate until September 14, 2022; however, there can be no assurances that this estimate is accurate.
In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic
205-40,
“Presentation of Financial Statements - Going Concern,” management has determined that the liquidity concerns, mandatory liquidation date and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to complete a business combination by September 14, 2022, then the Company will cease all operations except for the purpose of liquidating. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September 14, 2022.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
 
Use of Estimates
The preparation of these condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2022 and December 31, 2021, there were no cash equivalents held outside of the Trust Account.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of March 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” approximates the carrying amounts represented in the condensed balance sheets, other than investments held in Trust Account and derivative warrant liabilities, both of which are described below.
Investments Held in Trust Account
The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof.
When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. 
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
  •  
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period. Derivative warrant liabilities are classified as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statements of operations. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants.
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of the FASB ASC Topic
340-10-S99-1
and SEC Staff Accounting Bulletin Topic 5A—“Expenses of Offering.” Offering costs consisted of legal, accounting, underwriting commissions and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Public Shares were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, an aggregate of 32,408,414 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.
 
Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional
paid-in
capital (to the extent available) and accumulated deficit.
Income Taxes
FASB ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income, adjusted for the effects of a deemed dividend to Class A shareholders, by the weighted average ordinary shares outstanding for the respective period.
The calculation of diluted net income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of 
16,523,926
 ordinary shares in the calculation of diluted income per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the three months ended March 31, 2022 and 2021. The initial accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. Subsequent periods accretion of Class A ordinary shares subject to possible redemption is recognized as a deemed dividend to shareholders in the calculation of the net income per ordinary share. 
The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary share:
 
    
For the Three Months Ended March 31,
  
    
2022
     
2021
  
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income per ordinary share:
                                    
Numerator:
                                    
Allocation of net income available to ordinary shareholders
    $ 3,709,382      $ 927,345      $ 9,211,390      $ 2,302,847  
         
Denominator:
                                    
Basic and diluted weighted average ordinary shares outstanding
      32,408,414        8,102,103        32,408,414        8,102,103  
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income per common share
    $ 0.11      $ 0.11      $ 0.28      $ 0.28  
    
 
 
     
 
 
     
 
 
     
 
 
  
 
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Initial Public Offering
 3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Initial Public Offering
Note
3-Initial
Public Offering
On September 14, 2020, the Company consummated the Initial Public Offering of 30,000,000 units, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, inclusive of approximately $10.5 million in deferred underwriting commissions. The underwriters were granted a
45-day
option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On October 2, 2020, the underwriters partially exercised the Over-Allotment option to purchase an additional 2,408,414 units and on October 6, 2020, the Company completed the sale of the Over-Allotment Units to the underwriters, generating gross proceeds of approximately $24.1 million, and incurring additional offering costs of approximately $1.3 million in underwriting fees (inclusive of approximately $0.8 million in deferred underwriting commissions).
Each Unit consists of one Class A ordinary share and
one-third
of one redeemable warrant. Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7).
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Private Placement
 3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Private Placement
Note
4-Private
Placement
Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement with the purchase of 5,400,000 Private Placement Warrants by the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $8.1 million. Simultaneously with the closing of the Over-Allotment Units, on October 6, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 321,122 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $0.5 million.
Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be
non-redeemable
for cash and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.
The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Transactions
 3 Months Ended
Mar. 31, 2022
Related Party Transactions [Abstract]  
Related Party Transactions
Note
5-Related
Party Transactions
Founder Shares
On July 23, 2020, the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 8,625,000 Class B ordinary shares (the “Founder Shares”). The holders of the Founder Shares agreed to forfeit up to an aggregate of 1,125,000 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional units was not exercised in full by the underwriters, so that the Founder Shares would represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On September 3, 2020, the Sponsor transferred 20,000 Founder Shares to each of Cathleen Benko, Roger Crockett, Dixon Doll, Keyur Patel and Joanna Strober. Such Founder Shares are not subject to forfeiture in the event the underwriters’ Over-Allotment was not exercised. On October 2, 2020, the underwriters partially exercised the Over-Allotment option to purchase as additional 2,408,414 Units. On October 24, 2020 (the 45th day follow the Underwriting Agreement), 522,897 Class B ordinary shares were forfeited.
The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share
sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Sponsor and the Company’s founding team with respect to any Founder Shares, Private Placement Warrants and Class A ordinary shares issued upon conversion or exercise thereof. Notwithstanding the foregoing, if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share
sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the
lock-up.
Related Party Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.
The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.
Administrative Services Agreement
The Company entered into an agreement that provided that, commencing on the date that the Company’s securities are first listed on the New York Stock Exchange through the earlier of consummation of the initial Business Combination or the Company’s liquidation, the Company will pay the Sponsor $10,000 per month for office space, secretarial and administrative services. The Company incurred $30,000 and $30,000
 in expenses in connection with such services during the three months ended March 31, 2022 and 2021, respectively, as reflected in the administrative expenses—related party on the accompanying unaudited condensed statements of operations. As of March 31, 2022 and December 31, 2021, the Company had $
185,000 and $155,000, respectively, in accrued expenses in connection with such services as reflected in the accompanying condensed balance sheets.
In addition, the Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any
out-of-pocket
expenses incurred in connection with activities on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, executive officers or directors of the Company’s or their affiliates. Any such payments prior to an initial Business Combination will be made using of funds held outside the Trust Account.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note
6-Commitments
and Contingencies
Risk and Uncertainties
On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the
“COVID-19
outbreak”). In March 2020, the WHO classified the
COVID-19
outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the
COVID-19
outbreak continues to evolve. The impact of the
COVID-19
outbreak on the Company’s results of operations, financial position and cash flows will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the
COVID-19
outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s results of operations, financial position and cash flows may be materially adversely affected. Additionally, the Company’s ability to complete an initial Business Combination may be materially adversely affected due to significant governmental measures being implemented to contain the
COVID-19
outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial Business Combination in a timely manner. The Company’s ability to consummate an Initial Business Combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the
COVID-19
outbreak and the resulting market downturn.
Registration and Shareholder Rights
The holders of the Founder Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration and shareholder rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters a
45-day
option from the date of the prospectus to purchase up to 4,500,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On October 2, 2020, the underwriters partially exercised the Over-allotment option to purchase an additional 2,408,414 Units.
The underwriters were entitled to an underwriting discount of $0.20 per Unit, or $6.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $10.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
If the option to purchase additional units was exercised in full, the underwriters would have been entitled to an aggregate of $900,000 in fees payable upon closing and additional deferred underwriting commissions of approximately $1.6 million. On October 2, 2020, the Over-Allotment option was partially exercised, resulting in an underwriting discount of approximately $0.5 million deducted from the proceeds received for sale of the Over-Allotment Units, and approximately $0.8 million of deferred underwriting commissions.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Derivative Warrant Liabilities
 3 Months Ended
Mar. 31, 2022
Derivative Warrant Liabilities Disclosure [Abstract]  
Derivative Warrant Liabilities
Note
7-Derivative
Warrant Liabilities
As of March 31, 2022 and December 31, 2021, the Company had an aggregate of 16,523,926 warrants outstanding, comprised of 10,802,804 Public Warrants and 5,721,122 Private Warrants.
Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the
 
Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the “Newly Issued Price,” (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and 18.00 per share redemption trigger prices described below under “Redemption of warrants when the price per Class A ordinary share equal or exceed $10.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be
non-redeemable
so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the Initial Shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants):
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
  •  
if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share
sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”).
Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants:
 
  •  
in whole and not in part;
 
  •  
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares;
 
  •  
if, and only if, the Reference Value equals or exceeds $10.00 per Public Share (as adjusted per share
sub-divisions,
share dividends, reorganizations, recapitalizations and the like); and
 
  •  
if the Reference Value is less than $18.00 per share (as adjusted for share
sub-divisions,
share dividends, rights issuances,
sub-divisions,
reorganizations, recapitalizations and the like), then the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants as described above.
The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the
30-day
redemption period. Any such exercise would not be on a “cashless” basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised.
The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume-weighted average price of the Class A ordinary shares for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment).
If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Class A Ordinary Shares Subject to Possible Redemption
 3 Months Ended
Mar. 31, 2022
Temporary Equity Disclosure [Abstract]  
Class A Ordinary Shares Subject to Possible Redemption
Note
8-Class
A Ordinary Shares Subject to Possible Redemption
The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 200,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. As of March 31, 2022 and December 31, 2021, there were 32,408,414 Class A ordinary shares outstanding, which were all subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets.
 
The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets are reconciled on the following table:
 
    
March 31, 2022
     
December 31, 2021
  
Gross proceeds
    $ 324,084,140      $ 324,084,140  
Less:
                  
Amount allocated to Public Warrants
      (12,955,337 )       (12,955,337 ) 
Class A ordinary shares issuance costs
      (17,680,825 )       (17,680,825 ) 
Plus:
                  
Accretion of carrying value to redemption value
      30,694,026        30,636,162  
    
 
 
     
 
 
  
Class A ordinary shares subject to possible redemption
    $ 324,142,004      $ 324,084,140  
    
 
 
     
 
 
  
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders' Deficit
 3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Shareholders' Deficit
Note
9-Shareholders’
Deficit
Preference Shares-
The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share. As of March 31, 2022 and December 31, 2021, there were no preference shares issued or outstanding.
Class
 A Ordinary Shares-
The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of March 31, 2022 and December 31, 2021, there were 32,408,414 Class A ordinary shares issued and outstanding, all of which are subject to possible redemption and therefore classified as temporary equity in the accompanying condensed balance sheets (see Note 8).
Class
 B Ordinary Shares-
The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of March 31, 2022 and December 31, 2021, 8,102,103 Class B ordinary shares were issued and outstanding. Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law.
The Class B ordinary shares will automatically convert into Class A ordinary shares immediately upon the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an
as-converted
basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, members of the Company’s founding team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.
 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Note
10-Fair
Value Measurements
The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021 by level within the fair value hierarchy:
 
    
As of March 31, 2022
  
Description
   
Quoted Prices
in Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Assets:
                           
Investments held in Trust Account
    $ 324,242,004      $ —        $ —    
Liabilities:
                           
Derivative warrant liabilities-Public warrants
    $ 2,592,673      $ —        $ —    
Derivative warrant liabilities-Private placement warrants
    $ —        $ —        $ 1,373,069  
 
    
As of December 31, 2021
  
Description
   
Quoted Prices
in Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Assets:
                           
Investments held in Trust Account
    $ 324,211,180      $ —        $ —    
Liabilities:
                           
Derivative warrant liabilities-Public warrants
    $ 5,833,514      $ —        $ —    
Derivative warrant liabilities-Private placement warrants
    $ —        $ —        $ 3,089,406  
Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There were no transfers between levels of the hierarchy during the three-month periods ending March 31, 2022 and 2021.
Level 1 assets include investments in U.S. Treasury securities or money market funds that invest solely in U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value.
The fair value of the Public Warrants is measured based on the listed market price of such warrants, a Level 1 measurement. The estimated fair value of the Private Placement Warrant is based on a Monte Carlo simulation, which includes use of some Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its Class A ordinary shares warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s Class A ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury
zero-coupon
yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.
The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:
 
    
March 31,
2022
    
December 31,
2021
  
Exercise price
    $ 11.50     $ 11.50  
Stock price
    $ 9.89     $ 9.84  
Volatility
      3.6 %      9.3 % 
Term
      5.46       5.58  
Risk-free rate
      2.39 %      1.30 % 
Dividend yield
      0.0 %      0.0 % 
The change in the fair value of the derivative warrant liabilities measured with Level 3 inputs for the three months ended March 31, 2022 and March 31, 2021 is summarized as follows:
 
    
2022
     
2021
  
Level 3 derivative warrant liabilities at January 1,
    $ 3,089,406      $ 9,096,584  
Change in fair value of derivative warrant liabilities
      (1,716,337 )       (4,348,053 ) 
    
 
 
     
 
 
  
Level 3 derivative warrant liabilities at March 31,
    $ 1,373,069      $ 4,748,531  
    
 
 
     
 
 
  
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events
 3 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events
Note 10 — Subsequent Events
On April 28, 2022, Cathleen Benko resigned from the Company’s board of directors. Keyur Patel was appointed to the audit committee to fill the vacancy created by Ms. Benko’s resignation.
The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Basic of presentation
Basis of Presentation
The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 10 of Regulation
S-X.
Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these condensed financial statements as they are not required for interim financial statements under GAAP and the rules of the Securities and Exchange Commission. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form
10-K
for the year ended December 31, 2021, as filed with the SEC on March 21, 2022, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2021, is derived from the audited financial statements presented in the Company’s Annual Report on
Form 10-K
for the year ended December 31, 2021, as filed with the SEC on March 21, 2022.
Liquidity and Going Concern
Liquidity and Going Concern
As of March 31, 2022, the Company had approximately $0.6
 million in its operating bank account and working capital deficit of approximately $
4,000.
Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through the payment of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of approximately $98,000 pursuant to the Note (as defined in Note 5) issued to the Sponsor (Note 5). The Company repaid the Note in full on September 16, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of March 31, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loans.
The Company’s management plans to continue its efforts to complete a Business Combination within 24 months of the closing of the Initial Public Offering, or September 14, 2022. The Company believes that the funds currently available to it outside of the Trust Account will be sufficient to allow it to operate until September 14, 2022; however, there can be no assurances that this estimate is accurate.
In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic
205-40,
“Presentation of Financial Statements - Going Concern,” management has determined that the liquidity concerns, mandatory liquidation date and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to complete a business combination by September 14, 2022, then the Company will cease all operations except for the purpose of liquidating. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September 14, 2022.
Emerging Growth Company
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
 
Use of Estimates
Use of Estimates
The preparation of these condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2022 and December 31, 2021, there were no cash equivalents held outside of the Trust Account.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of March 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” approximates the carrying amounts represented in the condensed balance sheets, other than investments held in Trust Account and derivative warrant liabilities, both of which are described below.
Investments Held in Trust Account
Investments Held in Trust Account
The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof.
When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. 
Fair Value Measurements
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
  •  
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Warrant Liabilities
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period. Derivative warrant liabilities are classified as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statements of operations. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants.
Offering Costs Associated with the Initial Public Offering
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of the FASB ASC Topic
340-10-S99-1
and SEC Staff Accounting Bulletin Topic 5A—“Expenses of Offering.” Offering costs consisted of legal, accounting, underwriting commissions and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Public Shares were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, an aggregate of 32,408,414 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.
Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional
paid-in
capital (to the extent available) and accumulated deficit.
Income Taxes
Income Taxes
FASB ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income Per Ordinary Share
Net Income Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income, adjusted for the effects of a deemed dividend to Class A shareholders, by the weighted average ordinary shares outstanding for the respective period.
The calculation of diluted net income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of 
16,523,926
 ordinary shares in the calculation of diluted income per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the three months ended March 31, 2022 and 2021. The initial accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. Subsequent periods accretion of Class A ordinary shares subject to possible redemption is recognized as a deemed dividend to shareholders in the calculation of the net income per ordinary share. 
The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary share:
 
    
For the Three Months Ended March 31,
  
    
2022
     
2021
  
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income per ordinary share:
                                    
Numerator:
                                    
Allocation of net income available to ordinary shareholders
    $ 3,709,382      $ 927,345      $ 9,211,390      $ 2,302,847  
         
Denominator:
                                    
Basic and diluted weighted average ordinary shares outstanding
      32,408,414        8,102,103        32,408,414        8,102,103  
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income per common share
    $ 0.11      $ 0.11      $ 0.28      $ 0.28  
    
 
 
     
 
 
     
 
 
     
 
 
  
Recent Accounting Pronouncements
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Summary of Basic And Diluted Net Income per Share
The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary share:
 
    
For the Three Months Ended March 31,
  
    
2022
     
2021
  
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income per ordinary share:
                                    
Numerator:
                                    
Allocation of net income available to ordinary shareholders
    $ 3,709,382      $ 927,345      $ 9,211,390      $ 2,302,847  
         
Denominator:
                                    
Basic and diluted weighted average ordinary shares outstanding
      32,408,414        8,102,103        32,408,414        8,102,103  
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income per common share
    $ 0.11      $ 0.11      $ 0.28      $ 0.28  
    
 
 
     
 
 
     
 
 
     
 
 
  
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Class A Ordinary Shares Subject to Possible Redemption (Tables)
 3 Months Ended
Mar. 31, 2022
Temporary Equity Disclosure [Abstract]  
Schedule of Class A Ordinary Shares Subject to Possible Redemption
The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets are reconciled on the following table:
 
    
March 31, 2022
     
December 31, 2021
  
Gross proceeds
    $ 324,084,140      $ 324,084,140  
Less:
                  
Amount allocated to Public Warrants
      (12,955,337 )       (12,955,337 ) 
Class A ordinary shares issuance costs
      (17,680,825 )       (17,680,825 ) 
Plus:
                  
Accretion of carrying value to redemption value
      30,694,026        30,636,162  
    
 
 
     
 
 
  
Class A ordinary shares subject to possible redemption
    $ 324,142,004      $ 324,084,140  
    
 
 
     
 
 
  
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Summary of Assets that are Measured at Fair Value on a Recurring Basis
The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021 by level within the fair value hierarchy:
 
    
As of March 31, 2022
  
Description
   
Quoted Prices
in Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Assets:
                           
Investments held in Trust Account
    $ 324,242,004      $ —        $ —    
Liabilities:
                           
Derivative warrant liabilities-Public warrants
    $ 2,592,673      $ —        $ —    
Derivative warrant liabilities-Private placement warrants
    $ —        $ —        $ 1,373,069  
 
    
As of December 31, 2021
  
Description
   
Quoted Prices
in Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Assets:
                           
Investments held in Trust Account
    $ 324,211,180      $ —        $ —    
Liabilities:
                           
Derivative warrant liabilities-Public warrants
    $ 5,833,514      $ —        $ —    
Derivative warrant liabilities-Private placement warrants
    $ —        $ —        $ 3,089,406  
Summary of the Table Provides Quantitative Information Regarding Level 3 Fair Value Measurements Inputs at their Measurement Dates
The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:
 
    
March 31,
2022
    
December 31,
2021
  
Exercise price
    $ 11.50     $ 11.50  
Stock price
    $ 9.89     $ 9.84  
Volatility
      3.6 %      9.3 % 
Term
      5.46       5.58  
Risk-free rate
      2.39 %      1.30 % 
Dividend yield
      0.0 %      0.0 % 
Summary of Change in Fair Value of the Derivative Warrant Liabilities
The change in the fair value of the derivative warrant liabilities measured with Level 3 inputs for the three months ended March 31, 2022 and March 31, 2021 is summarized as follows:
 
    
2022
     
2021
  
Level 3 derivative warrant liabilities at January 1,
    $ 3,089,406      $ 9,096,584  
Change in fair value of derivative warrant liabilities
      (1,716,337 )       (4,348,053 ) 
    
 
 
     
 
 
  
Level 3 derivative warrant liabilities at March 31,
    $ 1,373,069      $ 4,748,531  
    
 
 
     
 
 
  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Description of Organization and Business Operations - Additional Information (Detail) - USD ($)
 3 Months Ended 12 Months Ended
Oct. 06, 2020
Oct. 02, 2020
Sep. 14, 2020
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Organisation Consolidation And Presentation Of Financial Statements And Significant Accounting Policies [Line Items]            
Deferred underwriting commission payable non current       $ 11,342,945 $ 11,342,945  
Class of warrants or rights exercise price per unit of warrant       $ 11.50    
Payments towards restricted investments       $ 324,100,000    
Term of restricted investments       185 days    
Minimum net worth needed post business combination       $ 5,000,001    
Percentage of the public shareholding that can be transferred without restriction       20.00%    
Percentage of public shareholding due to be redeemed in case of non occurrence of business combination       100.00%    
Time needed for consummation of business combination       24 months    
Due date for completion of business combination       Sep. 14, 2022    
Number of days after the due date for completion of business combination within which public shares shall be redeemed       10 days    
Estimated expenses payable on liquidation       $ 100,000    
Per share amount to be maintained in the trust account for redemption of public shares       $ 10.00    
Maximum [Member]            
Organisation Consolidation And Presentation Of Financial Statements And Significant Accounting Policies [Line Items]            
Per share amount to be maintained in the trust account for redemption of public shares       $ 10.00    
Minimum [Member]            
Organisation Consolidation And Presentation Of Financial Statements And Significant Accounting Policies [Line Items]            
Percentage of the net assets in the trust account of the prospective acquirer excluding taxes and deferred underwriting expenses       80.00%    
Equity method investment ownership percentage       50.00%    
Temporary equity redemption price per share       $ 10.00    
Per share amount to be maintained in the trust account for redemption of public shares       10.00    
Prime Impact Cayman LLC [Member]            
Organisation Consolidation And Presentation Of Financial Statements And Significant Accounting Policies [Line Items]            
Class of warrants or rights exercise price per unit of warrant       11.50    
Private Placement [Member]            
Organisation Consolidation And Presentation Of Financial Statements And Significant Accounting Policies [Line Items]            
Class of warrants or rights exercise price per unit of warrant       11.50    
Common Class A [Member]            
Organisation Consolidation And Presentation Of Financial Statements And Significant Accounting Policies [Line Items]            
Proceeds from initial public offer     $ 300,000,000.0      
Temporary equity redemption price per share       $ 10.00 $ 10.00  
Common Class A [Member] | IPO [Member]            
Organisation Consolidation And Presentation Of Financial Statements And Significant Accounting Policies [Line Items]            
Stock shares issued during the period during new issues shares     30,000,000      
Sale of stock issue price per share     $ 10.00      
Adjustment to additional paid in capital stock issuance costs       $ 17,100,000 $ 17,100,000  
Deferred underwriting commission payable non current       $ 10,500,000   $ 10,500,000
Common Class A [Member] | Over-Allotment Option [Member] | Prime Impact Cayman LLC [Member]            
Organisation Consolidation And Presentation Of Financial Statements And Significant Accounting Policies [Line Items]            
Stock shares issued during the period during new issues shares   2,408,414        
Sale of stock issue price per share       $ 10.00    
Deferred underwriting commission payable non current   $ 800,000        
Number of days granted to underwriters to subscribe to over-Allotment option       45 days 45 days  
Common stock shares issuable       4,500,000   4,500,000
Proceeds from issuance of common stock   24,100,000        
Underwriting expenses   $ 1,300,000        
Class of warrants or rights number of warrants issued during the period   800,000        
Private Placement Warrants [Member] | Private Placement [Member] | Prime Impact Cayman LLC [Member]            
Organisation Consolidation And Presentation Of Financial Statements And Significant Accounting Policies [Line Items]            
Class of warrants or rights number of warrants issued during the period 321,122   5,400,000      
Class of warrants or rights exercise price per unit of warrant     $ 11.50      
Class of warrants or rights issue price per unit of warrant     $ 1.50      
Proceeds from issue of warrants $ 500,000     $ 8,100,000    
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
 3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Accounting Policies [Line Items]    
Cash insured $ 250,000 $ 250,000
Unrecognized income tax benefits 0 0
Unrecognized income tax benefits accrued interest and penalty $ 0 $ 0
Restricted investments term 185 days  
Cash $ 600,000  
Net working capital deficit 4,000  
Working capital loan outstanding 0  
Prime Impact Cayman LLC [Member] | Related Party Note Tranche One [Member]    
Accounting Policies [Line Items]    
Proceeds from related party debt $ 98,000  
Common Class A [Member]    
Accounting Policies [Line Items]    
Common stock, shares subject to possible redemption 32,408,414  
Common Class A [Member] | Initial Public Offer Including Exercise Of The Over Allotment Option And Private Placement [Member]    
Accounting Policies [Line Items]    
Antidilutive securities excluded from the computation of earnings per share 16,523,926  
Common Class B [Member] | Prime Impact Cayman LLC [Member]    
Accounting Policies [Line Items]    
Stock shares issued during the period value for services rendered $ 25,000  
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies - Summary of Basic And Diluted Net Income per Share (Detail) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Basic and diluted net income (loss) per ordinary share:    
Allocation of net income (loss) $ 4,636,727 $ 11,514,237
Common Class A [Member]    
Basic and diluted net income (loss) per ordinary share:    
Allocation of net income (loss) $ 3,709,382 $ 9,211,390
Basic and diluted weighted average ordinary shares outstanding 32,408,414 32,408,414
Basic and diluted net income (loss) per ordinary share $ 0.11 $ 0.28
Common Class B [Member]    
Basic and diluted net income (loss) per ordinary share:    
Allocation of net income (loss) $ 927,345 $ 2,302,847
Basic and diluted weighted average ordinary shares outstanding 8,102,103 8,102,103
Basic and diluted net income (loss) per ordinary share $ 0.11 $ 0.28
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Initial Public Offering - Additional Information (Detail) - USD ($)
 3 Months Ended 12 Months Ended
Oct. 02, 2020
Sep. 14, 2020
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Subsidiary, Sale of Stock [Line Items]          
Class of warrants or rights exercise price per unit of warrant     $ 11.50    
Deferred underwriting commission payable non current     $ 11,342,945 $ 11,342,945  
Prime Impact Cayman LLC [Member]          
Subsidiary, Sale of Stock [Line Items]          
Class of warrants or rights exercise price per unit of warrant     $ 11.50    
Common Class A [Member]          
Subsidiary, Sale of Stock [Line Items]          
Proceeds from initial public offer   $ 300,000,000.0      
Common Class A [Member] | IPO [Member]          
Subsidiary, Sale of Stock [Line Items]          
Stock shares issued during the period during new issues shares   30,000,000      
Sale of stock issue price per share   $ 10.00      
Adjustment to additional paid in capital stock issuance costs     $ 17,100,000 $ 17,100,000  
Deferred underwriting commission payable non current     $ 10,500,000   $ 10,500,000
Common Class A [Member] | Over-Allotment Option [Member] | Prime Impact Cayman LLC [Member]          
Subsidiary, Sale of Stock [Line Items]          
Stock shares issued during the period during new issues shares 2,408,414        
Sale of stock issue price per share     $ 10.00    
Number of days granted to underwriters to subscribe to over-Allotment option     45 days 45 days  
Common stock shares issuable     4,500,000   4,500,000
Proceeds from issuance of common stock $ 24,100,000        
Underwriting expenses 1,300,000        
Deferred underwriting commission payable non current $ 800,000        
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Private Placement - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Oct. 06, 2020
Sep. 14, 2020
Mar. 31, 2022
Private Placement [Line Items]      
Class of warrants or rights exercise price per unit of warrant     $ 11.50
Prime Impact Cayman LLC [Member]      
Private Placement [Line Items]      
Class of warrants or rights exercise price per unit of warrant     11.50
Private Placement [Member]      
Private Placement [Line Items]      
Class of warrants or rights exercise price per unit of warrant     $ 11.50
Private Placement Warrants [Member] | Private Placement [Member] | Prime Impact Cayman LLC [Member]      
Private Placement [Line Items]      
Class of warrants or rights number of warrants issued during the period 321,122 5,400,000  
Class of warrants or rights exercise price per unit of warrant   $ 11.50  
Class of warrants or rights issue price per unit of warrant   $ 1.50  
Proceeds from issue of warrants $ 0.5   $ 8.1
Private Placement Warrants [Member] | Private Placement [Member] | Sponsors Officers And Directors [Member]      
Private Placement [Line Items]      
Class of warrants or rights lock in period post business combination     30 days
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Transactions - Additional Information (Detail) - USD ($)
 3 Months Ended
Oct. 24, 2021
Oct. 02, 2020
Mar. 31, 2022
Mar. 31, 2021
Related Party Transaction [Line Items]        
Ordinary shares forfeited 522,897      
Common Class A [Member] | Condition For Transfer Of Founder Shares Post Business Combination [Member] | Minimum [Member]        
Related Party Transaction [Line Items]        
Share price     $ 12.00  
Number of consecutive trading days for determining share price     20 days  
Number of trading days     30 days  
Number of days needed after the consummation of business combination     150 days  
Prime Impact Cayman LLC [Member] | Common Class B [Member]        
Related Party Transaction [Line Items]        
Stock shares issued during the period value for services rendered     $ 25,000  
Prime Impact Cayman LLC [Member] | Founder Shares [Member] | Common Class B [Member]        
Related Party Transaction [Line Items]        
Stock shares issued during the period value for services rendered     $ 25,000  
Stock shares issued during the period shares for services rendered     8,625,000  
Common stock shares subject to forfeiture     1,125,000  
Percentage of shareholding     20.00%  
Stock shares issued during the period during new issues shares   2,408,414    
Prime Impact Cayman LLC [Member] | Founder Shares [Member] | Common Class B [Member] | Restriction Of Share Transfer By Founders Post Business Combination [Member] | Minimum [Member]        
Related Party Transaction [Line Items]        
Share price     $ 12.00  
Number of consecutive trading days for determining share price     20 days  
Number of trading days     30 days  
Number of days needed after the consummation of business combination     150 days  
Joanna Strober [Member] | Founder Shares [Member] | Common Class B [Member]        
Related Party Transaction [Line Items]        
Common stock shares transferred and not subject to forfeiture     20,000  
Prime Impact Cayman LLC And Affiliates [Member] | Working Capital Loan Convertible Into Warrants [Member]        
Related Party Transaction [Line Items]        
Working capital loan convertible into warrants post business combination     $ 1,500,000  
Working capital loan convertible into warrants conversion price per warrant     $ 1.50  
Prime Impact Cayman LLC And Affiliates [Member] | Administrative Services Agreement [Member] | Securities To Be Listed Either At The Time Of Business Combination Or Liquidation [Member]        
Related Party Transaction [Line Items]        
Related party transaction administration and related expenses     $ 10,000  
Prime Impact Cayman LLC And Affiliates [Member] | Administrative Services Agreement [Member] | Securities To Be Listed Either At The Time Of Business Combination Or Liquidation [Member] | Accounts Payable and Accrued Liabilities [Member]        
Related Party Transaction [Line Items]        
Related party transaction administration and related expenses     185,000 $ 155,000
Prime Impact Cayman LLC And Affiliates [Member] | Administrative Services Agreement [Member] | Securities To Be Listed Either At The Time Of Business Combination Or Liquidation [Member] | Operating Expense [Member]        
Related Party Transaction [Line Items]        
Related party transaction administration and related expenses     $ 30,000 $ 30,000
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies - Additional Information (Detail) - USD ($)
 3 Months Ended 12 Months Ended
Oct. 02, 2020
Sep. 14, 2020
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Commitments And Contingencies [Line Items]          
Deferred underwriting commission non current     $ 11,342,945 $ 11,342,945  
Underwriting Agreement [Member]          
Commitments And Contingencies [Line Items]          
Deferred underwriting commission per share     $ 0.35    
Deferred underwriting commission non current     $ 10,500,000    
Over-Allotment Option [Member] | Underwriting Agreement [Member]          
Commitments And Contingencies [Line Items]          
Deferred underwriting commission non current $ 800,000        
Underwriter fee payable     900,000    
Additional deferred underwriting commission non current     $ 1,600,000    
Underwriting discount $ 500,000        
Over-Allotment Option [Member] | Prime Impact Cayman LLC [Member] | Common Class A [Member]          
Commitments And Contingencies [Line Items]          
Number of days granted to underwriters to subscribe to over-Allotment option     45 days 45 days  
Common stock shares issuable     4,500,000   4,500,000
Stock shares issued during the period during new issues shares 2,408,414        
Deferred underwriting commission non current $ 800,000        
Underwriting discount $ 1,300,000        
IPO [Member] | Underwriting Agreement [Member]          
Commitments And Contingencies [Line Items]          
Underwriting discount per share     $ 0.20    
Payment of stock issuance costs     $ 6,000,000.0    
IPO [Member] | Common Class A [Member]          
Commitments And Contingencies [Line Items]          
Stock shares issued during the period during new issues shares   30,000,000      
Deferred underwriting commission non current     $ 10,500,000   $ 10,500,000
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Derivative Warrant Liabilities - Additional Information (Detail) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Number of warrants or rights outstanding 16,523,926  
Warrants exercise price $ 11.50  
Warrants and rights outstanding, term 5 years  
Shares issued, price per share $ 9.20  
Percent of gross proceeds 60.00%  
Market Value One [Member]    
Volume-weighted average trading price $ 9.20  
Percent of redemption of warrants adjusted to market value 115.00%  
Market Value Two [Member]    
Volume-weighted average trading price $ 10.00  
Percent of redemption of warrants adjusted to market value 100.00%  
Market Value Three [Member]    
Volume-weighted average trading price $ 18.00  
Percent of redemption of warrants adjusted to market value 180.00%  
Common Class A [Member]    
Ratio of redemption feature per warrant 0.361  
Common Class A [Member] | Market Value Two [Member]    
Redemption price per warrant $ 0.10  
Common Class A [Member] | Market Value Three [Member]    
Redemption price per warrant $ 0.01  
Private Placement Warrants [Member]    
Number of warrants or rights outstanding   5,721,122
Public Warrants [Member]    
Number of warrants or rights outstanding 10,802,804  
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Detail) - Common Class A [Member] - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Redeemable Noncontrolling Interest [Line Items]    
Common stock shares authorized 200,000,000 200,000,000
Common stock par or stated value per share $ 0.0001 $ 0.0001
Temporary equity shares outstanding 32,408,414 32,408,414
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Class A Ordinary Shares Subject to Possible Redemption - Summary of Ordinary shares Subject to Possible Redemption (Detail) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Temporary Equity Disclosure [Abstract]    
Gross proceeds $ 324,084,140 $ 324,084,140
Amount allocated to Public Warrants (12,955,337) (12,955,337)
Class A ordinary shares issuance costs (17,680,825) (17,680,825)
Accretion of carrying value to redemption value 30,694,026 30,636,162
Class A ordinary shares subject to possible redemption $ 324,142,004 $ 324,084,140
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders' Deficit - Additional Information (Detail) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Class of Stock [Line Items]    
Preferred stock par or stated value per share $ 0.0001 $ 0.0001
Preferred stock shares authorized 1,000,000 1,000,000
Preferred stock shares issued 0 0
Preferred stock shares outstanding 0 0
Common Class A [Member]    
Class of Stock [Line Items]    
Common stock shares authorized 200,000,000 200,000,000
Common stock par or stated value per share $ 0.0001 $ 0.0001
Common stock shares issued 0 0
Common stock shares outstanding 0 0
Common Class A [Member] | Common Stock [Member]    
Class of Stock [Line Items]    
Common stock shares issued 32,408,414 32,408,414
Common stock shares outstanding 32,408,414 32,408,414
Common Class B [Member]    
Class of Stock [Line Items]    
Common stock shares authorized 20,000,000 20,000,000
Common stock par or stated value per share $ 0.0001 $ 0.0001
Common stock shares issued 8,102,103 8,102,103
Common stock shares outstanding 8,102,103 8,102,103
Percentage of amount of convertible shares to be issued 20.00%  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements - Summary of Assets that are Measured at Fair Value on a Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Assets, fair value disclosure $ 324,242,004 $ 324,211,180
Fair Value, Inputs, Level 1 [Member] | Warrant Liabilities | Public Warrants [Member]    
Liabilities:    
Financial Liabilities Fair Value Disclosure 2,592,673 5,833,514
Fair Value, Inputs, Level 1 [Member] | Warrant Liabilities | Private Placement Warrants [Member]    
Liabilities:    
Financial Liabilities Fair Value Disclosure 0 0
Fair Value, Inputs, Level 2 [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Assets, fair value disclosure 0 0
Fair Value, Inputs, Level 2 [Member] | Warrant Liabilities | Public Warrants [Member]    
Liabilities:    
Financial Liabilities Fair Value Disclosure 0 0
Fair Value, Inputs, Level 2 [Member] | Warrant Liabilities | Private Placement Warrants [Member]    
Liabilities:    
Financial Liabilities Fair Value Disclosure 0 0
Fair Value, Inputs, Level 3 [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Assets, fair value disclosure 0 0
Fair Value, Inputs, Level 3 [Member] | Warrant Liabilities | Public Warrants [Member]    
Liabilities:    
Financial Liabilities Fair Value Disclosure 0 0
Fair Value, Inputs, Level 3 [Member] | Warrant Liabilities | Private Placement Warrants [Member]    
Liabilities:    
Financial Liabilities Fair Value Disclosure $ 1,373,069 $ 3,089,406
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements - Summary of the Table Provides Quantitative Information Regarding Level 3 Fair Value Measurements Inputs at their Measurement Dates (Detail) - Level 3 - $ / shares
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Exercise price $ 11.50 $ 11.50
Stock price $ 9.89 $ 9.84
Volatility 3.60% 9.30%
Term 5 years 5 months 15 days 5 years 6 months 29 days
Risk-free rate 2.39% 1.30%
Dividend yield 0.00% 0.00%
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements - Summary of Change in Fair Value of the Derivative Warrant Liabilities (Detail) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Disclosure Of Change In Fair Value Of The Derivative Warrant Liabilities [Line Items]    
Level 3 derivative warrant liabilities at Beginning Balance $ 8,922,920  
Change in fair value of derivative warrant liabilities (4,957,178) $ (12,018,044)
Level 3 derivative warrant liabilities at Ending Balance 3,965,742  
Level 3    
Disclosure Of Change In Fair Value Of The Derivative Warrant Liabilities [Line Items]    
Level 3 derivative warrant liabilities at Beginning Balance 3,089,406 9,096,584
Change in fair value of derivative warrant liabilities (1,716,337) (4,348,053)
Level 3 derivative warrant liabilities at Ending Balance $ 1,373,069 $ 4,748,531
XML 46 d352893d10q_htm.xml IDEA: XBRL DOCUMENT 0001819175 2022-01-01 2022-03-31 0001819175 2021-12-31 0001819175 2022-03-31 0001819175 2021-01-01 2021-03-31 0001819175 2021-10-24 2021-10-24 0001819175 2021-01-01 2021-12-31 0001819175 2020-12-31 0001819175 2021-03-31 0001819175 us-gaap:CommonClassBMember 2022-03-31 0001819175 us-gaap:CommonClassAMember 2022-03-31 0001819175 srt:MinimumMember 2022-03-31 0001819175 srt:MaximumMember 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember 2022-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-03-31 0001819175 us-gaap:PrivatePlacementMember 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassBMember piai:FounderSharesMember 2022-03-31 0001819175 srt:MinimumMember piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassBMember piai:RestrictionOfShareTransferByFoundersPostBusinessCombinationMember piai:FounderSharesMember 2022-03-31 0001819175 srt:MinimumMember us-gaap:CommonClassAMember piai:ConditionForTransferOfFounderSharesPostBusinessCombinationMember 2022-03-31 0001819175 piai:WorkingCapitalLoanConvertibleIntoWarrantsMember piai:PrimeImpactCaymanLlcAndAffiliatesMember 2022-03-31 0001819175 piai:UnderwritingAgreementMember 2022-03-31 0001819175 us-gaap:OverAllotmentOptionMember piai:UnderwritingAgreementMember 2022-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001819175 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001819175 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001819175 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001819175 piai:PublicWarrantsMember 2022-03-31 0001819175 piai:MarketValueOneMember 2022-03-31 0001819175 piai:MarketValueTwoMember 2022-03-31 0001819175 piai:MarketValueThreeMember 2022-03-31 0001819175 us-gaap:CommonClassAMember piai:MarketValueThreeMember 2022-03-31 0001819175 us-gaap:CommonClassAMember piai:MarketValueTwoMember 2022-03-31 0001819175 piai:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001819175 piai:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001819175 piai:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001819175 piai:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001819175 piai:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001819175 piai:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001819175 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001819175 us-gaap:CommonClassBMember 2021-12-31 0001819175 us-gaap:CommonClassAMember 2021-12-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001819175 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 piai:PrivatePlacementWarrantsMember 2021-12-31 0001819175 piai:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 piai:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 piai:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 piai:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 piai:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 piai:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member piai:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001819175 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001819175 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001819175 us-gaap:CapitalUnitsMember 2022-01-01 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember piai:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassAMember piai:InitialPublicOfferIncludingExerciseOfTheOverAllotmentOptionAndPrivatePlacementMember 2022-01-01 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-01 2022-03-31 0001819175 piai:PrivatePlacementWarrantsMember piai:PrimeImpactCaymanLlcMember us-gaap:PrivatePlacementMember 2022-01-01 2022-03-31 0001819175 piai:PrivatePlacementWarrantsMember piai:SponsorsOfficersAndDirectorsMember us-gaap:PrivatePlacementMember 2022-01-01 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassBMember piai:FounderSharesMember 2022-01-01 2022-03-31 0001819175 piai:JoannaStroberMember us-gaap:CommonClassBMember piai:FounderSharesMember 2022-01-01 2022-03-31 0001819175 srt:MinimumMember piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassBMember piai:RestrictionOfShareTransferByFoundersPostBusinessCombinationMember piai:FounderSharesMember 2022-01-01 2022-03-31 0001819175 srt:MinimumMember us-gaap:CommonClassAMember piai:ConditionForTransferOfFounderSharesPostBusinessCombinationMember 2022-01-01 2022-03-31 0001819175 piai:AdministrativeServicesAgreementMember piai:PrimeImpactCaymanLlcAndAffiliatesMember piai:SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember 2022-01-01 2022-03-31 0001819175 us-gaap:OperatingExpenseMember piai:AdministrativeServicesAgreementMember piai:PrimeImpactCaymanLlcAndAffiliatesMember piai:SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember 2022-01-01 2022-03-31 0001819175 us-gaap:AccountsPayableAndAccruedLiabilitiesMember piai:AdministrativeServicesAgreementMember piai:PrimeImpactCaymanLlcAndAffiliatesMember piai:SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember 2022-01-01 2022-03-31 0001819175 us-gaap:IPOMember piai:UnderwritingAgreementMember 2022-01-01 2022-03-31 0001819175 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001819175 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-03-31 0001819175 us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001819175 piai:RelatedPartyNoteTrancheOneMember piai:PrimeImpactCaymanLlcMember 2022-01-01 2022-03-31 0001819175 us-gaap:OperatingExpenseMember piai:AdministrativeServicesAgreementMember piai:PrimeImpactCaymanLlcAndAffiliatesMember piai:SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember 2021-01-01 2021-03-31 0001819175 us-gaap:AccountsPayableAndAccruedLiabilitiesMember piai:AdministrativeServicesAgreementMember piai:PrimeImpactCaymanLlcAndAffiliatesMember piai:SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember 2021-01-01 2021-03-31 0001819175 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001819175 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001819175 us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-03-31 0001819175 us-gaap:CommonClassAMember 2021-01-01 2021-03-31 0001819175 us-gaap:CommonClassBMember 2021-01-01 2021-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-09-14 2020-09-14 0001819175 us-gaap:CommonClassAMember 2020-09-14 2020-09-14 0001819175 piai:PrimeImpactCaymanLlcMember piai:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2020-09-14 2020-09-14 0001819175 piai:PrivatePlacementWarrantsMember piai:PrimeImpactCaymanLlcMember us-gaap:PrivatePlacementMember 2020-09-14 2020-09-14 0001819175 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-09-14 0001819175 piai:PrimeImpactCaymanLlcMember piai:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2020-09-14 0001819175 piai:PrivatePlacementWarrantsMember piai:PrimeImpactCaymanLlcMember us-gaap:PrivatePlacementMember 2020-09-14 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2020-10-02 2020-10-02 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassBMember piai:FounderSharesMember 2020-10-02 2020-10-02 0001819175 us-gaap:OverAllotmentOptionMember piai:UnderwritingAgreementMember 2020-10-02 2020-10-02 0001819175 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-01-01 2021-12-31 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2021-01-01 2021-12-31 0001819175 us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001819175 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-09-30 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2021-09-30 0001819175 piai:PrimeImpactCaymanLlcMember piai:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2020-10-06 2020-10-06 0001819175 piai:PrivatePlacementWarrantsMember piai:PrimeImpactCaymanLlcMember us-gaap:PrivatePlacementMember 2020-10-06 2020-10-06 0001819175 piai:PrimeImpactCaymanLlcMember us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2020-10-02 0001819175 us-gaap:OverAllotmentOptionMember piai:UnderwritingAgreementMember 2020-10-02 0001819175 us-gaap:WarrantMember 2022-05-11 0001819175 us-gaap:CommonClassBMember 2022-05-11 0001819175 us-gaap:CommonClassAMember 2022-05-11 0001819175 us-gaap:RetainedEarningsMember 2021-12-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001819175 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001819175 us-gaap:RetainedEarningsMember 2022-03-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001819175 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001819175 us-gaap:RetainedEarningsMember 2020-12-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001819175 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001819175 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001819175 us-gaap:FairValueInputsLevel3Member 2021-03-31 0001819175 us-gaap:RetainedEarningsMember 2021-03-31 0001819175 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001819175 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001819175 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 iso4217:USD shares utr:Day pure utr:Month utr:Year iso4217:USD shares false Q1 --12-31 0001819175 CA P10D 10-Q true 2022-03-31 2022 false 001-39501 Prime Impact Acquisition I E9 98-1554335 123 E San Carlos Street Suite 12 San Jose 95112 650 825-6965 Units, each consisting of one Class A ordinary share and one-third of a Warrant to acquire one Class A ordinary share PIAI.U NYSE Class A ordinary shares, par value $0.0001 per share PIAI NYSE Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PIAI.W NYSE Yes Yes Non-accelerated Filer true true false true 29071732 8102103 15411670 626428 665940 73750 110626 700178 776566 324242004 324211180 324942182 324987746 488099 327477 215936 159535 704035 487012 3965742 8922920 11342945 11342945 16012722 20752877 0.0001 0.0001 32408414 32408414 32408414 32408414 10.00 10.00 324142004 324084140 0.0001 0.0001 1000000 1000000 0 0 0 0 0.0001 0.0001 200000000 200000000 0 0 0 0 0 0 0.0001 0.0001 20000000 20000000 8102103 8102103 8102103 8102103 810 810 0 0 -15213354 -19850081 -15212544 -19849271 324942182 324987746 263428 491586 30000 30000 -293428 -521586 -4957178 -12018044 17 46 30824 17733 4694591 11514237 57864 0 4636727 11514237 32408414 32408414 0.11 0.28 8102103 8102103 0.11 0.28 0 0 8102103 810 0 -19850081 -19849271 0 0 0 4694591 4694591 57864 57864 0 0 8102103 810 0 -15213354 -15212544 0 0 8102103 810 0 -35618082 -35617272 0 0 0 11514237 11514237 0 0 8102103 810 0 -24103845 -24103035 4694591 11514237 -4957178 -12018044 30824 17733 -36876 -73098 160622 369533 56401 30000 -39512 -48909 -39512 -48909 665940 1600255 626428 1551346 -57864 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 1 — Description of Organization and Business Operations </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prime Impact Acquisition I (the “Company”) was incorporated as a Cayman Islands exempted company on July 21, 2020. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of March 31, 2022, the Company had not commenced any operations. All activity for the period from July 21, 2020 (inception) through March 31, 2022 relates to the Company’s formation and the preparation of the initial public offering described below (the “Initial Public Offering”), and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company’s sponsor is Prime Impact Cayman, LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Initial Public Offering was declared effective on September 9, 2020. On September 14, 2020, the Company consummated the Initial Public Offering of 30,000,000 units (each, a “Unit” and collectively, the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, inclusive of approximately $10.5 million in deferred underwriting commissions (Note 6). The underwriters were granted a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">45-day</div> option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On October 2, 2020, the underwriters partially exercised the over-allotment option to purchase an additional 2,408,414 units (the “Over-Allotment Units”). On October 6, 2020, the Company completed the sale of the Over-Allotment Units to the underwriters (the “Over-Allotment”), generating gross proceeds of approximately $24.1 million, and incurring additional offering costs of approximately $1.3 million in underwriting fees (inclusive of approximately $0.8 million in deferred underwriting commissions). </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 5,400,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $8.1 million (Note 4). Simultaneously with the closing of the Over-Allotment Units, on October 6, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an additional 321,122 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $0.5 million. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Upon the closing of the Initial Public Offering and the Private Placement, $324.1 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering, the Over-Allotment and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer &amp; Trust Company acting as trustee and was invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount) at the time the Company signs a definitive </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company will provide its holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which will be adopted by the Company upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares (as defined in Note 5) prior to this Initial Public Offering (the “Initial Shareholders”) have agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company has agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s Sponsor, executive officers, directors and director nominees have agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or September 14, 2022 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:hidden47493020">ten</span> business days thereafter, redeem the Public Shares, at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses). </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </div></div> 30000000 10.00 300000000.0 17100000 10500000 P45D 4500000 2408414 24100000 1300000 800000 5400000 11.50 1.50 8100000 321122 500000 324100000 P185D 0.80 0.50 10.00 5000001 0.20 1 P24M 2022-09-14 100000 100000 10.00 10.00 10.00 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 2 — Basis of Presentation and Summary of Significant Accounting Policies </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 10 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X.</div> Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these condensed financial statements as they are not required for interim financial statements under GAAP and the rules of the Securities and Exchange Commission. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the year ended December 31, 2021, as filed with the SEC on March 21, 2022, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2021, is derived from the audited financial statements presented in the Company’s Annual Report on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 10-K</div> for the year ended December 31, 2021, as filed with the SEC on March 21, 2022. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Liquidity and Going Concern </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2022, the Company had approximately $0.6<div style="text-indent: 0px;;display:inline;"> million in its operating bank account and working capital deficit of approximately $</div>4,000. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through the payment of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of approximately $98,000 pursuant to the Note (as defined in Note 5) issued to the Sponsor (Note 5). The Company repaid the Note in full on September 16, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of March 31, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loans. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management plans to continue its efforts to complete a Business Combination within 24 months of the closing of the Initial Public Offering, or September 14, 2022. The Company believes that the funds currently available to it outside of the Trust Account will be sufficient to allow it to operate until September 14, 2022; however, there can be no assurances that this estimate is accurate. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">205-40,</div> “Presentation of Financial Statements - Going Concern,” management has determined that the liquidity concerns, mandatory liquidation date and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to complete a business combination by September 14, 2022, then the Company will cease all operations except for the purpose of liquidating. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September 14, 2022. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging Growth Company </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of these condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2022 and December 31, 2021, there were no cash equivalents held outside of the Trust Account. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of March 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value of Financial Instruments </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” approximates the carrying amounts represented in the condensed balance sheets, other than investments held in Trust Account and derivative warrant liabilities, both of which are described below. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments Held in Trust Account </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. <div style="letter-spacing: 0px; top: 0px;;display:inline;">When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. </div> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></div> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Warrant Liabilities </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-assessed</div> at the end of each reporting period. Derivative warrant liabilities are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;">The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statements of operations. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Offering Costs Associated with the Initial Public Offering </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;">The Company complies with the requirements of the FASB ASC Topic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-10-S99-1</div></div></div> and SEC Staff Accounting Bulletin Topic 5A—“Expenses of Offering.” Offering costs consisted of legal, accounting, underwriting commissions and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Public Shares were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A Ordinary Shares Subject to Possible Redemption </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, an aggregate of 32,408,414 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital (to the extent available) and accumulated deficit. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FASB ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Income Per Ordinary Share </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income, adjusted for the effects of a deemed dividend to Class A shareholders, by the weighted average ordinary shares outstanding for the respective period. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="display:inline;">The calculation of diluted net income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of </div>16,523,926<div style="display:inline;"> ordinary shares in the calculation of diluted income per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the three months ended March 31, 2022 and 2021. The initial accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. Subsequent periods accretion of Class A ordinary shares subject to possible redemption is recognized as a deemed dividend to shareholders in the calculation of the net income per ordinary share. </div> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary share: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income available to ordinary shareholders</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,709,382</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">927,345</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,211,390</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,302,847</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average ordinary shares outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,408,414</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,102,103</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,408,414</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,102,103</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per common share</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.28</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.28</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 10 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X.</div> Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these condensed financial statements as they are not required for interim financial statements under GAAP and the rules of the Securities and Exchange Commission. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the year ended December 31, 2021, as filed with the SEC on March 21, 2022, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2021, is derived from the audited financial statements presented in the Company’s Annual Report on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 10-K</div> for the year ended December 31, 2021, as filed with the SEC on March 21, 2022. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Liquidity and Going Concern </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2022, the Company had approximately $0.6<div style="text-indent: 0px;;display:inline;"> million in its operating bank account and working capital deficit of approximately $</div>4,000. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through the payment of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of approximately $98,000 pursuant to the Note (as defined in Note 5) issued to the Sponsor (Note 5). The Company repaid the Note in full on September 16, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of March 31, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loans. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management plans to continue its efforts to complete a Business Combination within 24 months of the closing of the Initial Public Offering, or September 14, 2022. The Company believes that the funds currently available to it outside of the Trust Account will be sufficient to allow it to operate until September 14, 2022; however, there can be no assurances that this estimate is accurate. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">205-40,</div> “Presentation of Financial Statements - Going Concern,” management has determined that the liquidity concerns, mandatory liquidation date and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to complete a business combination by September 14, 2022, then the Company will cease all operations except for the purpose of liquidating. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September 14, 2022. </div> 600000 4000 25000 98000 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging Growth Company </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of these condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2022 and December 31, 2021, there were no cash equivalents held outside of the Trust Account. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of March 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div> 250000 250000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value of Financial Instruments </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” approximates the carrying amounts represented in the condensed balance sheets, other than investments held in Trust Account and derivative warrant liabilities, both of which are described below. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments Held in Trust Account </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. <div style="letter-spacing: 0px; top: 0px;;display:inline;">When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. </div> </div></div> P185D <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></div> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Warrant Liabilities </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-assessed</div> at the end of each reporting period. Derivative warrant liabilities are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;">The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statements of operations. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Offering Costs Associated with the Initial Public Offering </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;">The Company complies with the requirements of the FASB ASC Topic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-10-S99-1</div></div></div> and SEC Staff Accounting Bulletin Topic 5A—“Expenses of Offering.” Offering costs consisted of legal, accounting, underwriting commissions and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Public Shares were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A Ordinary Shares Subject to Possible Redemption </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, an aggregate of 32,408,414 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital (to the extent available) and accumulated deficit. </div> 32408414 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FASB ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div></div> 0 0 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Income Per Ordinary Share </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income, adjusted for the effects of a deemed dividend to Class A shareholders, by the weighted average ordinary shares outstanding for the respective period. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="display:inline;">The calculation of diluted net income per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of </div>16,523,926<div style="display:inline;"> ordinary shares in the calculation of diluted income per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the three months ended March 31, 2022 and 2021. The initial accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. Subsequent periods accretion of Class A ordinary shares subject to possible redemption is recognized as a deemed dividend to shareholders in the calculation of the net income per ordinary share. </div> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary share: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income available to ordinary shareholders</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,709,382</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">927,345</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,211,390</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,302,847</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average ordinary shares outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,408,414</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,102,103</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,408,414</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,102,103</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per common share</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.28</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.28</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 16523926 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary share: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income available to ordinary shareholders</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,709,382</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">927,345</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,211,390</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,302,847</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average ordinary shares outstanding</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,408,414</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,102,103</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,408,414</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,102,103</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per common share</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.11</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.28</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.28</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 3709382 927345 9211390 2302847 32408414 8102103 32408414 8102103 0.11 0.11 0.28 0.28 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3-Initial</div> Public Offering </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On September 14, 2020, the Company consummated the Initial Public Offering of 30,000,000 units, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, inclusive of approximately $10.5 million in deferred underwriting commissions. The underwriters were granted a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">45-day</div> option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On October 2, 2020, the underwriters partially exercised the Over-Allotment option to purchase an additional 2,408,414 units and on October 6, 2020, the Company completed the sale of the Over-Allotment Units to the underwriters, generating gross proceeds of approximately $24.1 million, and incurring additional offering costs of approximately $1.3 million in underwriting fees (inclusive of approximately $0.8 million in deferred underwriting commissions). </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Each Unit consists of one Class A ordinary share and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-third</div> of one redeemable warrant. Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7). </div> 30000000 10.00 300000000.0 17100000 10500000 P45D 4500000 10.00 2408414 24100000 1300000 800000 11.50 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4-Private</div> Placement </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement with the purchase of 5,400,000 Private Placement Warrants by the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $8.1 million. Simultaneously with the closing of the Over-Allotment Units, on October 6, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 321,122 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $0.5 million. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> for cash and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. </div></div> 5400000 11.50 1.50 8100000 321122 500000 11.50 P30D <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5-Related</div> Party Transactions </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Founder Shares </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July 23, 2020, the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 8,625,000 Class B ordinary shares (the “Founder Shares”). The holders of the Founder Shares agreed to forfeit up to an aggregate of 1,125,000 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional units was not exercised in full by the underwriters, so that the Founder Shares would represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On September 3, 2020, the Sponsor transferred 20,000 Founder Shares to each of Cathleen Benko, Roger Crockett, Dixon Doll, Keyur Patel and Joanna Strober. Such Founder Shares are not subject to forfeiture in the event the underwriters’ Over-Allotment was not exercised. On October 2, 2020, the underwriters partially exercised the Over-Allotment option to purchase as additional 2,408,414 Units. On October 24, 2020 (the 45th day follow the Underwriting Agreement), 522,897 Class B ordinary shares were forfeited. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-divisions,</div> share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Sponsor and the Company’s founding team with respect to any Founder Shares, Private Placement Warrants and Class A ordinary shares issued upon conversion or exercise thereof. Notwithstanding the foregoing, if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-divisions,</div> share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up.</div> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Related Party Loans </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Administrative Services Agreement </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company entered into an agreement that provided that, commencing on the date that the Company’s securities are first listed on the New York Stock Exchange through the earlier of consummation of the initial Business Combination or the Company’s liquidation, the Company will pay the Sponsor $10,000 per month for office space, secretarial and administrative services. The Company incurred $30,000 and $30,000<div style="text-indent: 0px;;display:inline;"> in expenses in connection with such services during the three months ended March 31, 2022 and 2021, respectively, as reflected in the administrative expenses—related party on the accompanying unaudited condensed statements of operations. As of March 31, 2022 and December 31, 2021, the Company had $</div>185,000 and $155,000, respectively, in accrued expenses in connection with such services as reflected in the accompanying condensed balance sheets. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In addition, the Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">out-of-pocket</div></div> expenses incurred in connection with activities on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, executive officers or directors of the Company’s or their affiliates. Any such payments prior to an initial Business Combination will be made using of funds held outside the Trust Account. </div> 25000 8625000 1125000 0.20 20000 2408414 522897 12.00 P20D P30D P150D 12.00 P20D P30D P150D 1500000 1.50 10000 30000 30000 185000 155000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">6-Commitments</div> and Contingencies </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risk and Uncertainties </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“COVID-19</div> outbreak”). In March 2020, the WHO classified the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> outbreak continues to evolve. The impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> outbreak on the Company’s results of operations, financial position and cash flows will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s results of operations, financial position and cash flows may be materially adversely affected. Additionally, the Company’s ability to complete an initial Business Combination may be materially adversely affected due to significant governmental measures being implemented to contain the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial Business Combination in a timely manner. The Company’s ability to consummate an Initial Business Combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> outbreak and the resulting market downturn. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Registration and Shareholder Rights </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The holders of the Founder Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration and shareholder rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Underwriting Agreement </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company granted the underwriters a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">45-day</div> option from the date of the prospectus to purchase up to 4,500,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On October 2, 2020, the underwriters partially exercised the Over-allotment option to purchase an additional 2,408,414 Units. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The underwriters were entitled to an underwriting discount of $0.20 per Unit, or $6.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $10.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the option to purchase additional units was exercised in full, the underwriters would have been entitled to an aggregate of $900,000 in fees payable upon closing and additional deferred underwriting commissions of approximately $1.6 million. On October 2, 2020, the Over-Allotment option was partially exercised, resulting in an underwriting discount of approximately $0.5 million deducted from the proceeds received for sale of the Over-Allotment Units, and approximately $0.8 million of deferred underwriting commissions. </div></div> P45D 4500000 2408414 0.20 6000000.0 0.35 10500000 900000 1600000 500000 800000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">7-Derivative</div> Warrant Liabilities </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2022 and December 31, 2021, the Company had an aggregate of 16,523,926 warrants outstanding, comprised of 10,802,804 Public Warrants and 5,721,122 Private Warrants. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the “Newly Issued Price,” (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and 18.00 per share redemption trigger prices described below under “Redemption of warrants when the price per Class A ordinary share equal or exceed $10.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the Initial Shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants): </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.01 per warrant; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and </div></div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-divisions,</div> share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”). </div></td></tr></table><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the Reference Value equals or exceeds $10.00 per Public Share (as adjusted per share <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-divisions,</div> share dividends, reorganizations, recapitalizations and the like); and </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if the Reference Value is less than $18.00 per share (as adjusted for share <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-divisions,</div> share dividends, rights issuances, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-divisions,</div> reorganizations, recapitalizations and the like), then the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants as described above. </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> redemption period. Any such exercise would not be on a “cashless” basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume-weighted average price of the Class A ordinary shares for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </div></div> 16523926 10802804 5721122 11.50 P5Y 9.20 0.60 9.20 1.15 10.00 18.00 1 1.80 0.01 0.10 0.361 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-Class</div> A Ordinary Shares Subject to Possible Redemption </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 200,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. As of March 31, 2022 and December 31, 2021, there were 32,408,414 Class A ordinary shares outstanding, which were all subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets are reconciled on the following table: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 67%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross proceeds</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,084,140</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,084,140</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amount allocated to Public Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,955,337</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,955,337</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares issuance costs</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,680,825</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,680,825</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,694,026</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,636,162</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,142,004</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,084,140</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 200000000 0.0001 32408414 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets are reconciled on the following table: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 67%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross proceeds</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,084,140</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,084,140</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amount allocated to Public Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,955,337</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,955,337</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares issuance costs</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,680,825</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,680,825</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,694,026</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,636,162</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,142,004</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,084,140</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 324084140 324084140 12955337 12955337 17680825 17680825 30694026 30636162 324142004 324084140 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">9-Shareholders’</div> Deficit </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preference Shares- </div></div></div></div>The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share. As of March 31, 2022 and December 31, 2021, there were no preference shares issued or outstanding. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A Ordinary Shares- </div></div></div></div>The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of March 31, 2022 and December 31, 2021, there were 32,408,414 Class A ordinary shares issued and outstanding, all of which are subject to possible redemption and therefore classified as temporary equity in the accompanying condensed balance sheets (see Note 8). </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> B Ordinary Shares- </div></div></div></div>The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of March 31, 2022 and December 31, 2021, 8,102,103 Class B ordinary shares were issued and outstanding. Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Class B ordinary shares will automatically convert into Class A ordinary shares immediately upon the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, members of the Company’s founding team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> 1000000 1000000 0.0001 0.0001 0 0 0 0 200000000 0.0001 32408414 32408414 32408414 32408414 20000000 0.0001 8102103 8102103 8102103 8102103 0.20 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Fair</div> Value Measurements </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021 by level within the fair value hierarchy: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices<br/> in Active<br/> Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,242,004</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities-Public warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,592,673</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities-Private placement warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,373,069</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices<br/> in Active<br/> Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,211,180</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities-Public warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,833,514</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities-Private placement warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,089,406</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There were no transfers between levels of the hierarchy during the three-month periods ending March 31, 2022 and 2021. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1 assets include investments in U.S. Treasury securities or money market funds that invest solely in U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The fair value of the Public Warrants is measured based on the listed market price of such warrants, a Level 1 measurement. The estimated fair value of the Private Placement Warrant is based on a Monte Carlo simulation, which includes use of some Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its Class A ordinary shares warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s Class A ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">zero-coupon</div> yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 75%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock price</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.89</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.84</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.3</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.46</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.58</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.39</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.30</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in the fair value of the derivative warrant liabilities measured with Level 3 inputs for the three months ended March 31, 2022 and March 31, 2021 is summarized as follows: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 73%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 derivative warrant liabilities at January 1,</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,089,406</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,096,584</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liabilities</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,716,337</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,348,053</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 derivative warrant liabilities at March 31,</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,373,069</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,748,531</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021 by level within the fair value hierarchy: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of March 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices<br/> in Active<br/> Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,242,004</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities-Public warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,592,673</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities-Private placement warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,373,069</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices<br/> in Active<br/> Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">324,211,180</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities-Public warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,833,514</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities-Private placement warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,089,406</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> 324242004 0 0 2592673 0 0 0 0 1373069 324211180 0 0 5833514 0 0 0 0 3089406 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 75%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock price</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.89</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.84</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.6</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.3</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.46</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.58</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.39</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.30</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td></tr></table> 11.50 11.50 9.89 9.84 0.036 0.093 P5Y5M15D P5Y6M29D 0.0239 0.0130 0.000 0.000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in the fair value of the derivative warrant liabilities measured with Level 3 inputs for the three months ended March 31, 2022 and March 31, 2021 is summarized as follows: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 73%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 derivative warrant liabilities at January 1,</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,089,406</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,096,584</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liabilities</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,716,337</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,348,053</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 derivative warrant liabilities at March 31,</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,373,069</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,748,531</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 3089406 9096584 -1716337 -4348053 1373069 4748531 <div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 10 — Subsequent Events </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On April 28, 2022, Cathleen Benko resigned from the Company’s board of directors. Keyur Patel was appointed to the audit committee to fill the vacancy created by Ms. Benko’s resignation. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 48 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 125 185 1 false 38 0 false 7 false false R1.htm 1001 - Document - Cover Page Sheet http://www.iposcoop.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Balance sheets Sheet http://www.iposcoop.com/role/CondensedBalanceSheets Condensed Balance sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Balance sheets (Parenthetical) Sheet http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical Condensed Balance sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Statements of Operations Sheet http://www.iposcoop.com/role/CondensedStatementsOfOperations Condensed Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Condensed Statements of Changes in Shareholders' Deficit Sheet http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit Condensed Statements of Changes in Shareholders' Deficit Statements 5 false false R6.htm 1006 - Statement - Condensed Statements of Cash Flows Sheet http://www.iposcoop.com/role/CondensedStatementsOfCashFlows Condensed Statements of Cash Flows Statements 6 false false R7.htm 1007 - Disclosure - Description of Organization and Business Operations Sheet http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperations Description of Organization and Business Operations Notes 7 false false R8.htm 1008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Initial Public Offering Sheet http://www.iposcoop.com/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 1010 - Disclosure - Private Placement Sheet http://www.iposcoop.com/role/PrivatePlacement Private Placement Notes 10 false false R11.htm 1011 - Disclosure - Related Party Transactions Sheet http://www.iposcoop.com/role/RelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 1012 - Disclosure - Commitments and Contingencies Sheet http://www.iposcoop.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 1013 - Disclosure - Derivative Warrant Liabilities Sheet http://www.iposcoop.com/role/DerivativeWarrantLiabilities Derivative Warrant Liabilities Notes 13 false false R14.htm 1014 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption Sheet http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption Class A Ordinary Shares Subject to Possible Redemption Notes 14 false false R15.htm 1015 - Disclosure - Shareholders' Deficit Sheet http://www.iposcoop.com/role/ShareholdersDeficit Shareholders' Deficit Notes 15 false false R16.htm 1016 - Disclosure - Fair Value Measurements Sheet http://www.iposcoop.com/role/FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 1017 - Disclosure - Subsequent Events Sheet http://www.iposcoop.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 1018 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 18 false false R19.htm 1019 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 19 false false R20.htm 1020 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Tables) Sheet http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables Class A Ordinary Shares Subject to Possible Redemption (Tables) Tables http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption 20 false false R21.htm 1021 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.iposcoop.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.iposcoop.com/role/FairValueMeasurements 21 false false R22.htm 1022 - Disclosure - Description of Organization and Business Operations - Additional Information (Detail) Sheet http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail Description of Organization and Business Operations - Additional Information (Detail) Details 22 false false R23.htm 1023 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) Details 23 false false R24.htm 1024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Basic And Diluted Net Income per Share (Detail) Sheet http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail Basis of Presentation and Summary of Significant Accounting Policies - Summary of Basic And Diluted Net Income per Share (Detail) Details 24 false false R25.htm 1025 - Disclosure - Initial Public Offering - Additional Information (Detail) Sheet http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail Initial Public Offering - Additional Information (Detail) Details 25 false false R26.htm 1026 - Disclosure - Private Placement - Additional Information (Detail) Sheet http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail Private Placement - Additional Information (Detail) Details 26 false false R27.htm 1027 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 27 false false R28.htm 1028 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 28 false false R29.htm 1029 - Disclosure - Derivative Warrant Liabilities - Additional Information (Detail) Sheet http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail Derivative Warrant Liabilities - Additional Information (Detail) Details 29 false false R30.htm 1030 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Detail) Sheet http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAdditionalInformationDetail Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Detail) Details 30 false false R31.htm 1031 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption - Summary of Ordinary shares Subject to Possible Redemption (Detail) Sheet http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionSummaryOfOrdinarySharesSubjectToPossibleRedemptionDetail Class A Ordinary Shares Subject to Possible Redemption - Summary of Ordinary shares Subject to Possible Redemption (Detail) Details 31 false false R32.htm 1032 - Disclosure - Shareholders' Deficit - Additional Information (Detail) Sheet http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail Shareholders' Deficit - Additional Information (Detail) Details 32 false false R33.htm 1033 - Disclosure - Fair Value Measurements - Summary of Assets that are Measured at Fair Value on a Recurring Basis (Detail) Sheet http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail Fair Value Measurements - Summary of Assets that are Measured at Fair Value on a Recurring Basis (Detail) Details 33 false false R34.htm 1034 - Disclosure - Fair Value Measurements - Summary of the Table Provides Quantitative Information Regarding Level 3 Fair Value Measurements Inputs at their Measurement Dates (Detail) Sheet http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail Fair Value Measurements - Summary of the Table Provides Quantitative Information Regarding Level 3 Fair Value Measurements Inputs at their Measurement Dates (Detail) Details 34 false false R35.htm 1035 - Disclosure - Fair Value Measurements - Summary of Change in Fair Value of the Derivative Warrant Liabilities (Detail) Sheet http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesDetail Fair Value Measurements - Summary of Change in Fair Value of the Derivative Warrant Liabilities (Detail) Details 35 false false All Reports Book All Reports d352893d10q.htm d352893dex311.htm d352893dex312.htm d352893dex321.htm d352893dex322.htm piai-20220331.xsd piai-20220331_cal.xml piai-20220331_def.xml piai-20220331_lab.xml piai-20220331_pre.xml http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 53 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d352893d10q.htm": { "axisCustom": 5, "axisStandard": 12, "contextCount": 125, "dts": { "calculationLink": { "local": [ "piai-20220331_cal.xml" ] }, "definitionLink": { "local": [ "piai-20220331_def.xml" ] }, "inline": { "local": [ "d352893d10q.htm" ] }, "labelLink": { "local": [ "piai-20220331_lab.xml" ] }, "presentationLink": { "local": [ "piai-20220331_pre.xml" ] }, "schema": { "local": [ "piai-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 322, "entityCount": 1, "hidden": { "http://www.iposcoop.com/20220331": 1, "http://xbrl.sec.gov/dei/2021": 5, "total": 6 }, "keyCustom": 51, "keyStandard": 134, "memberCustom": 19, "memberStandard": 18, "nsprefix": "piai", "nsuri": "http://www.iposcoop.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://www.iposcoop.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "piai:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Private Placement", "role": "http://www.iposcoop.com/role/PrivatePlacement", "shortName": "Private Placement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "piai:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Related Party Transactions", "role": "http://www.iposcoop.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Commitments and Contingencies", "role": "http://www.iposcoop.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "piai:DerivativeWarrantLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Derivative Warrant Liabilities", "role": "http://www.iposcoop.com/role/DerivativeWarrantLiabilities", "shortName": "Derivative Warrant Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "piai:DerivativeWarrantLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "piai:TemporaryEquityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption", "role": "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption", "shortName": "Class A Ordinary Shares Subject to Possible Redemption", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "piai:TemporaryEquityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Shareholders' Deficit", "role": "http://www.iposcoop.com/role/ShareholdersDeficit", "shortName": "Shareholders' Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Fair Value Measurements", "role": "http://www.iposcoop.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Subsequent Events", "role": "http://www.iposcoop.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "piai:BasicOfPresentationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "role": "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "piai:BasicOfPresentationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "role": "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Condensed Balance sheets", "role": "http://www.iposcoop.com/role/CondensedBalanceSheets", "shortName": "Condensed Balance sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Tables)", "role": "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables", "shortName": "Class A Ordinary Shares Subject to Possible Redemption (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.iposcoop.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "piai:DeferredUnderwritingCommissionsPayableNonCurrent", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Description of Organization and Business Operations - Additional Information (Detail)", "role": "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "shortName": "Description of Organization and Business Operations - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": "-5", "lang": null, "name": "us-gaap:PaymentsToAcquireRestrictedInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:CashFDICInsuredAmount", "div", "div", "us-gaap:ConcentrationRiskCreditRisk", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)", "role": "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CashFDICInsuredAmount", "div", "div", "us-gaap:ConcentrationRiskCreditRisk", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Basic And Diluted Net Income per Share (Detail)", "role": "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Summary of Basic And Diluted Net Income per Share (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Initial Public Offering - Additional Information (Detail)", "role": "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "shortName": "Initial Public Offering - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Private Placement - Additional Information (Detail)", "role": "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail", "shortName": "Private Placement - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "piai:PrivatePlacementTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P10_06_2020To10_06_2020_PrimeImpactCaymanLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "INF", "lang": null, "name": "piai:ClassOfWarrantsOrRightsNumberOfWarrantsIssuedDuringThePeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P10_24_2021To10_24_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Related Party Transactions - Additional Information (Detail)", "role": "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P10_24_2021To10_24_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "piai:DeferredUnderwritingCommissionsPayableNonCurrent", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "role": "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022_UnderwritingAgreementMemberPIAiAgreementAxis", "decimals": "2", "lang": null, "name": "piai:DeferredUnderwritingCommissionPayablePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "piai:DerivativeWarrantLiabilitiesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Derivative Warrant Liabilities - Additional Information (Detail)", "role": "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail", "shortName": "Derivative Warrant Liabilities - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "piai:DerivativeWarrantLiabilitiesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Condensed Balance sheets (Parenthetical)", "role": "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "shortName": "Condensed Balance sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:TemporaryEquityParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "4", "lang": null, "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Detail)", "role": "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAdditionalInformationDetail", "shortName": "Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:TemporaryEquityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "piai:TemporaryEquityGrossProceeds", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption - Summary of Ordinary shares Subject to Possible Redemption (Detail)", "role": "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionSummaryOfOrdinarySharesSubjectToPossibleRedemptionDetail", "shortName": "Class A Ordinary Shares Subject to Possible Redemption - Summary of Ordinary shares Subject to Possible Redemption (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:TemporaryEquityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "piai:TemporaryEquityGrossProceeds", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Shareholders' Deficit - Additional Information (Detail)", "role": "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail", "shortName": "Shareholders' Deficit - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockSharesOutstanding", "us-gaap:CommonStockSharesOutstanding", "us-gaap:CommonStockSharesIssued", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Fair Value Measurements - Summary of Assets that are Measured at Fair Value on a Recurring Basis (Detail)", "role": "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail", "shortName": "Fair Value Measurements - Summary of Assets that are Measured at Fair Value on a Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Fair Value Measurements - Summary of the Table Provides Quantitative Information Regarding Level 3 Fair Value Measurements Inputs at their Measurement Dates (Detail)", "role": "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail", "shortName": "Fair Value Measurements - Summary of the Table Provides Quantitative Information Regarding Level 3 Fair Value Measurements Inputs at their Measurement Dates (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn03_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "piai:DerivativeWarrantLiabilities", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - Fair Value Measurements - Summary of Change in Fair Value of the Derivative Warrant Liabilities (Detail)", "role": "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesDetail", "shortName": "Fair Value Measurements - Summary of Change in Fair Value of the Derivative Warrant Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "piai:DisclosureOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "0", "lang": null, "name": "piai:DerivativeWarrantLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Condensed Statements of Operations", "role": "http://www.iposcoop.com/role/CondensedStatementsOfOperations", "shortName": "Condensed Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Condensed Statements of Changes in Shareholders' Deficit", "role": "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "shortName": "Condensed Statements of Changes in Shareholders' Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Condensed Statements of Cash Flows", "role": "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows", "shortName": "Condensed Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInPrepaidExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - Description of Organization and Business Operations", "role": "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperations", "shortName": "Description of Organization and Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies", "role": "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "piai:InitialPublicOfferTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Initial Public Offering", "role": "http://www.iposcoop.com/role/InitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d352893d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "piai:InitialPublicOfferTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 38, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "piai_AccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting policies.", "label": "Accounting Policies [Line Items]" } } }, "localname": "AccountingPoliciesLineItems", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_AccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting policies.", "label": "Accounting Policies [Table]" } } }, "localname": "AccountingPoliciesTable", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_AdditionalDeferredUnderwritingCommissionNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Additional deferred underwriting commission non current.", "label": "Additional Deferred Underwriting Commission Non Current", "terseLabel": "Additional deferred underwriting commission non current" } } }, "localname": "AdditionalDeferredUnderwritingCommissionNonCurrent", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "piai_AdministrativeServicesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Administrative services agreement.", "label": "Administrative Services Agreement [Member]", "terseLabel": "Administrative Services Agreement [Member]" } } }, "localname": "AdministrativeServicesAgreementMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement [Axis].", "label": "Agreement [Axis]", "terseLabel": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Domain]", "terseLabel": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_BasicOfPresentationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic of presentation.", "label": "Basic Of Presentation [Policy Text Block]", "terseLabel": "Basic of presentation" } } }, "localname": "BasicOfPresentationPolicyTextBlock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "piai_ChangeInFairValueOfDerivativeWarrantLiabilities": { "auth_ref": [], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.iposcoop.com/role/CondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of derivative warrant liabilities.", "label": "Change In Fair Value Of Derivative Warrant Liabilities", "negatedLabel": "Change in fair value of derivative warrant liabilities", "terseLabel": "Change in fair value of derivative warrant liabilities" } } }, "localname": "ChangeInFairValueOfDerivativeWarrantLiabilities", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows", "http://www.iposcoop.com/role/CondensedStatementsOfOperations", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "piai_ClassOfWarrantsOrRightsIssuePricePerUnitOfWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights issue price per unit of warrant.", "label": "Class Of Warrants Or Rights Issue Price Per Unit Of Warrant", "terseLabel": "Class of warrants or rights issue price per unit of warrant" } } }, "localname": "ClassOfWarrantsOrRightsIssuePricePerUnitOfWarrant", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "piai_ClassOfWarrantsOrRightsLockInPeriodPostBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights lock in period post business combination.", "label": "Class Of Warrants Or Rights Lock In Period Post Business Combination", "terseLabel": "Class of warrants or rights lock in period post business combination" } } }, "localname": "ClassOfWarrantsOrRightsLockInPeriodPostBusinessCombination", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "piai_ClassOfWarrantsOrRightsNumberOfWarrantsIssuedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights number of warrants issued during the period.", "label": "Class Of Warrants Or Rights Number Of Warrants Issued During The Period", "terseLabel": "Class of warrants or rights number of warrants issued during the period" } } }, "localname": "ClassOfWarrantsOrRightsNumberOfWarrantsIssuedDuringThePeriod", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "piai_CommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies [Line items].", "label": "Commitments And Contingencies [Line Items]" } } }, "localname": "CommitmentsAndContingenciesLineItems", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_CommitmentsAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies [Table].", "label": "Commitments And Contingencies [Table]" } } }, "localname": "CommitmentsAndContingenciesTable", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_CommonStockSharesSubjectToPossibleRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock, shares subject to possible redemption.", "label": "Common Stock Shares Subject To Possible Redemption", "terseLabel": "Common stock, shares subject to possible redemption" } } }, "localname": "CommonStockSharesSubjectToPossibleRedemption", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "piai_CommonStockSharesTransferredAndNotSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock shares transferred and not subject to forfeiture.", "label": "Common Stock Shares Transferred And Not Subject To Forfeiture", "terseLabel": "Common stock shares transferred and not subject to forfeiture" } } }, "localname": "CommonStockSharesTransferredAndNotSubjectToForfeiture", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "piai_ConditionForDuesPayableToRelatedPartyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Condition for dues payable to related party [Axis].", "label": "Condition For Dues Payable To Related Party [Axis]", "terseLabel": "Condition For Dues Payable To Related Party [Axis]" } } }, "localname": "ConditionForDuesPayableToRelatedPartyAxis", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_ConditionForDuesPayableToRelatedPartyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Condition for dues payable to related party.", "label": "Condition For Dues Payable To Related Party [Domain]", "terseLabel": "Condition For Dues Payable To Related Party [Domain]" } } }, "localname": "ConditionForDuesPayableToRelatedPartyDomain", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_ConditionForTransferOfFounderSharesPostBusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Condition for transfer of founder shares post business combination.", "label": "Condition For Transfer Of Founder Shares Post Business Combination [Member]", "terseLabel": "Condition For Transfer Of Founder Shares Post Business Combination [Member]" } } }, "localname": "ConditionForTransferOfFounderSharesPostBusinessCombinationMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_DeemedDividendIncreaseInRedemptionValueOfClassaOrdinarySharesSubjectToRedemption": { "auth_ref": [], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deemed dividend increase in redemption value of class\u00a0A ordinary shares subject to redemption.", "label": "Deemed Dividend Increase In Redemption Value Of ClassA Ordinary Shares Subject To Redemption", "negatedLabel": "Deemed dividend - increase in redemption value of Class A ordinary shares subject to redemption" } } }, "localname": "DeemedDividendIncreaseInRedemptionValueOfClassaOrdinarySharesSubjectToRedemption", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "http://www.iposcoop.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "piai_DeferredUnderwritingCommissionPayablePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commission payable per share.", "label": "Deferred Underwriting Commission Payable Per Share", "terseLabel": "Deferred underwriting commission per share" } } }, "localname": "DeferredUnderwritingCommissionPayablePerShare", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "piai_DeferredUnderwritingCommissionsPayableNonCurrent": { "auth_ref": [], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Deferred underwriting commission non current", "documentation": "Deferred underwriting commissions payable non current.", "label": "Deferred Underwriting Commissions Payable Non Current", "terseLabel": "Deferred underwriting commissions", "verboseLabel": "Deferred underwriting commission payable non current" } } }, "localname": "DeferredUnderwritingCommissionsPayableNonCurrent", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CondensedBalanceSheets", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "piai_DerivativeWarrantLiabilities": { "auth_ref": [], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Derivative warrant liabilities.", "label": "Derivative Warrant Liabilities", "periodEndLabel": "Level 3 derivative warrant liabilities at Ending Balance", "periodStartLabel": "Level 3 derivative warrant liabilities at Beginning Balance", "verboseLabel": "Derivative warrant liabilities" } } }, "localname": "DerivativeWarrantLiabilities", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "piai_DerivativeWarrantLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative Warrant Liabilities Disclosure.", "label": "Derivative Warrant Liabilities Disclosure [Abstract]" } } }, "localname": "DerivativeWarrantLiabilitiesDisclosureAbstract", "nsuri": "http://www.iposcoop.com/20220331", "xbrltype": "stringItemType" }, "piai_DerivativeWarrantLiabilitiesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative Warrant Liabilities Disclosure.", "label": "Derivative Warrant Liabilities Disclosure [Text Block]", "terseLabel": "Derivative Warrant Liabilities" } } }, "localname": "DerivativeWarrantLiabilitiesDisclosureTextBlock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilities" ], "xbrltype": "textBlockItemType" }, "piai_DerivativeWarrantLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative Warrant liabilities.", "label": "Derivative Warrant liabilities [Policy Text Block]", "terseLabel": "Derivative Warrant Liabilities" } } }, "localname": "DerivativeWarrantLiabilitiesPolicyTextBlock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "piai_DisclosureOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of change in fair value of the derivative warrant liabilities.", "label": "Disclosure of change in fair value of the derivative warrant liabilities [Abstract]" } } }, "localname": "DisclosureOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesAbstract", "nsuri": "http://www.iposcoop.com/20220331", "xbrltype": "stringItemType" }, "piai_DisclosureOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of change in fair value of the derivative warrant liabilities.", "label": "Disclosure Of Change In Fair Value Of The Derivative Warrant Liabilities [Line Items]" } } }, "localname": "DisclosureOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesLineItems", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "piai_DisclosureOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of change in fair value of the derivative warrant liabilities.", "label": "Disclosure Of Change In Fair Value Of The Derivative Warrant Liabilities [Table]" } } }, "localname": "DisclosureOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesTable", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "piai_DisclosureOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of change in fair value of the derivative warrant liabilities.", "label": "Disclosure of change in fair value of the derivative warrant liabilities [Table Text Block]", "terseLabel": "Summary of Change in Fair Value of the Derivative Warrant Liabilities" } } }, "localname": "DisclosureOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesTableTextBlock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "piai_DueDateForCompletionOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Due date for completion of business combination.", "label": "Due Date For Completion Of Business Combination", "terseLabel": "Due date for completion of business combination" } } }, "localname": "DueDateForCompletionOfBusinessCombination", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "piai_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Emerging growth company.", "label": "Emerging Growth Company [Policy Text Block]", "terseLabel": "Emerging Growth Company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "piai_EventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Event [Axis].", "label": "Event [Axis]", "terseLabel": "Event [Axis]" } } }, "localname": "EventAxis", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_EventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Event.", "label": "Event [Domain]", "terseLabel": "Event [Domain]" } } }, "localname": "EventDomain", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_FairValueAssetsMeasuredOnRecurringBasisAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assets measured on recurring basis [abstract].", "label": "Fair Value Assets Measured On Recurring Basis [Abstract]", "terseLabel": "Fair Value Assets Measured On Recurring Basis [Abstract]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisAbstract", "nsuri": "http://www.iposcoop.com/20220331", "xbrltype": "stringItemType" }, "piai_FairValueAssetsMeasuredOnRecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assets measured on recurring basis [line item].", "label": "Fair Value Assets Measured On Recurring Basis [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisLineItems", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "stringItemType" }, "piai_FairValueAssetsMeasuredOnRecurringBasisTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assets measured on recurring basis [table].", "label": "Fair Value Assets Measured On Recurring Basis [Table]", "terseLabel": "Fair Value Assets Measured On Recurring Basis [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTable", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "stringItemType" }, "piai_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder shares.", "label": "Founder Shares [Member]", "terseLabel": "Founder Shares [Member]" } } }, "localname": "FounderSharesMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_InitialPublicOfferIncludingExerciseOfTheOverAllotmentOptionAndPrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Public Offer Including Exercise Of The Over Allotment Option And Private Placement.", "label": "Initial Public Offer Including Exercise Of The Over Allotment Option And Private Placement [Member]" } } }, "localname": "InitialPublicOfferIncludingExerciseOfTheOverAllotmentOptionAndPrivatePlacementMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_InitialPublicOfferTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offer [Text block].", "label": "Initial Public Offer [Text Block]", "terseLabel": "Initial Public Offering" } } }, "localname": "InitialPublicOfferTextBlock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "piai_JoannaStroberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Joanna Strober.", "label": "Joanna Strober [Member]", "terseLabel": "Joanna Strober [Member]" } } }, "localname": "JoannaStroberMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_LiquidityAndGoingConcernPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liquidity and going concern", "label": "Liquidity And Going Concern [Policy Text Block]", "terseLabel": "Liquidity and Going Concern" } } }, "localname": "LiquidityAndGoingConcernPolicyTextBlock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "piai_MarketPriceTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market price type [Axis].", "label": "Market Price Type [Axis]", "terseLabel": "Market Price Type [Axis]" } } }, "localname": "MarketPriceTypeAxis", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_MarketPriceTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market Price Type.", "label": "Market Price Type [Domain]", "terseLabel": "Market Price Type [Domain]" } } }, "localname": "MarketPriceTypeDomain", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_MarketValueOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market value one.", "label": "Market Value One [Member]", "terseLabel": "Market Value One [Member]" } } }, "localname": "MarketValueOneMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_MarketValueThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market value three.", "label": "Market Value Three [Member]", "terseLabel": "Market Value Three [Member]" } } }, "localname": "MarketValueThreeMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_MarketValueTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market value two.", "label": "Market Value Two [Member]", "terseLabel": "Market Value Two [Member]" } } }, "localname": "MarketValueTwoMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_NetWorkingCapitalDeficit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net working capital deficit.", "label": "Net Working Capital Deficit", "terseLabel": "Net working capital deficit" } } }, "localname": "NetWorkingCapitalDeficit", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "piai_NumberOfConsecutiveTradingDaysAfterDeterminingTheSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of consecutive trading days after determining the share price.", "label": "Number Of Consecutive Trading Days After Determining The Share Price", "terseLabel": "Number of consecutive trading days for determining share price" } } }, "localname": "NumberOfConsecutiveTradingDaysAfterDeterminingTheSharePrice", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "piai_NumberOfDaysAfterTheDueDateForCompletionOfBusinessCombinationWithinWhichPublicSharesShallBeRedeemed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of days after the due date for completion of business combination within which public shares shall be redeemed.", "label": "Number Of Days After The Due Date For Completion Of Business Combination Within Which Public Shares Shall Be Redeemed", "terseLabel": "Number of days after the due date for completion of business combination within which public shares shall be redeemed" } } }, "localname": "NumberOfDaysAfterTheDueDateForCompletionOfBusinessCombinationWithinWhichPublicSharesShallBeRedeemed", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "piai_NumberOfDaysGrantedToUnderwritersToSubscribeSharesPursuantToOverallotmentOption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of days granted to underwriters to subscribe shares pursuant to overallotment option.", "label": "Number Of Days Granted To Underwriters To Subscribe Shares Pursuant To Overallotment Option", "terseLabel": "Number of days granted to underwriters to subscribe to over-Allotment option" } } }, "localname": "NumberOfDaysGrantedToUnderwritersToSubscribeSharesPursuantToOverallotmentOption", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "piai_NumberOfDaysNeededAfterTheConsummationOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of days needed after the consummation of business combination.", "label": "Number Of Days Needed After The Consummation Of Business Combination", "terseLabel": "Number of days needed after the consummation of business combination" } } }, "localname": "NumberOfDaysNeededAfterTheConsummationOfBusinessCombination", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "piai_NumberOfTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of trading days.", "label": "Number Of Trading Days", "terseLabel": "Number of trading days" } } }, "localname": "NumberOfTradingDays", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "piai_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Offering costs associated with initial public offering [Policy text block].", "label": "Offering Costs Associated With Initial Public Offering [Policy Text Block]", "terseLabel": "Offering Costs Associated with the Initial Public Offering" } } }, "localname": "OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "piai_OrganisationConsolidationAndPresentationOfFinancialStatementsAndSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organisation consolidation and presentation of financial statements and significant accounting policies [Line items].", "label": "Organisation Consolidation And Presentation Of Financial Statements And Significant Accounting Policies [Line Items]" } } }, "localname": "OrganisationConsolidationAndPresentationOfFinancialStatementsAndSignificantAccountingPoliciesLineItems", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_OrganisationConsolidationAndPresentationOfFinancialStatementsAndSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organisation consolidation and presentation of financial statements and significant accounting policies [Table].", "label": "Organisation Consolidation And Presentation Of Financial Statements And Significant Accounting Policies [Table]" } } }, "localname": "OrganisationConsolidationAndPresentationOfFinancialStatementsAndSignificantAccountingPoliciesTable", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_PerShareAmountToBeMaintainedInTheTrustAccountForTheRedemptionOfPublicShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount to be maintained in the trust account for the redemption of public shares.", "label": "Per Share Amount To Be Maintained In The Trust Account For The Redemption Of Public Shares", "terseLabel": "Per share amount to be maintained in the trust account for redemption of public shares" } } }, "localname": "PerShareAmountToBeMaintainedInTheTrustAccountForTheRedemptionOfPublicShares", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "piai_PercentOfGrossProceeds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percent of gross proceeds.", "label": "Percent Of Gross Proceeds", "terseLabel": "Percent of gross proceeds" } } }, "localname": "PercentOfGrossProceeds", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "piai_PercentOfRedemptionOfWarrantsAdjustedToMarketValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percent of redemption of warrants adjusted to market value.", "label": "Percent Of Redemption Of Warrants Adjusted To Market Value", "terseLabel": "Percent of redemption of warrants adjusted to market value" } } }, "localname": "PercentOfRedemptionOfWarrantsAdjustedToMarketValue", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "piai_PercentageOfAmountOfConvertibleSharesToBeIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of amount of convertible shares to be issued.", "label": "Percentage Of Amount Of Convertible Shares To Be Issued", "terseLabel": "Percentage of amount of convertible shares to be issued" } } }, "localname": "PercentageOfAmountOfConvertibleSharesToBeIssued", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "piai_PercentageOfNetAssetsInTheTrustAccountOfTheProspectiveAcquirerExcludingTaxesAndDeferredUnderwritingExpenses": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of net assets in the trust account of the prospective acquirer excluding taxes and deferred underwriting expenses.", "label": "Percentage Of Net Assets In The Trust Account Of The Prospective Acquirer Excluding Taxes And Deferred Underwriting Expenses", "terseLabel": "Percentage of the net assets in the trust account of the prospective acquirer excluding taxes and deferred underwriting expenses" } } }, "localname": "PercentageOfNetAssetsInTheTrustAccountOfTheProspectiveAcquirerExcludingTaxesAndDeferredUnderwritingExpenses", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "piai_PercentageOfShareholding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of shareholding.", "label": "Percentage Of Shareholding", "terseLabel": "Percentage of shareholding" } } }, "localname": "PercentageOfShareholding", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "piai_PercentageOfThePublicShareholdingThatCanBeTransferredWithoutRestriction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of the public shareholding that can be transferred without restriction", "label": "Percentage Of The Public Shareholding That Can Be Transferred Without Restriction", "terseLabel": "Percentage of the public shareholding that can be transferred without restriction" } } }, "localname": "PercentageOfThePublicShareholdingThatCanBeTransferredWithoutRestriction", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "piai_PercentageOfThePublicShareholdingToBeRedeemedInCaseOfNonOccurrenceOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of the public shareholding to be redeemed in case of non occurrence of business combination.", "label": "Percentage Of The Public Shareholding To Be Redeemed In Case Of Non Occurrence Of Business Combination", "terseLabel": "Percentage of public shareholding due to be redeemed in case of non occurrence of business combination" } } }, "localname": "PercentageOfThePublicShareholdingToBeRedeemedInCaseOfNonOccurrenceOfBusinessCombination", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "piai_PrimeImpactCaymanLlcAndAffiliatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prime impact cayman LLC and affiliates.", "label": "Prime Impact Cayman LLC And Affiliates [Member]", "terseLabel": "Prime Impact Cayman LLC And Affiliates [Member]" } } }, "localname": "PrimeImpactCaymanLlcAndAffiliatesMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_PrimeImpactCaymanLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prime impact cayman LLC.", "label": "Prime Impact Cayman LLC [Member]", "terseLabel": "Prime Impact Cayman LLC [Member]" } } }, "localname": "PrimeImpactCaymanLlcMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_PrivatePlacementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement [Line items].", "label": "Private Placement [Line Items]" } } }, "localname": "PrivatePlacementLineItems", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_PrivatePlacementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement.", "label": "Private Placement [Table]" } } }, "localname": "PrivatePlacementTable", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement [Text block].", "label": "Private Placement [Text Block]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/PrivatePlacement" ], "xbrltype": "textBlockItemType" }, "piai_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement warrants.", "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants [Member]" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public warrants [Member].", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants [Member]" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "piai_RatioOfRedemptionFeaturePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratio of redemption feature per warrant.", "label": "Ratio Of Redemption Feature Per Warrant", "terseLabel": "Ratio of redemption feature per warrant" } } }, "localname": "RatioOfRedemptionFeaturePerWarrant", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "piai_ReclassificationDescriptionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reclassification Description.", "label": "Reclassification Description [Axis]" } } }, "localname": "ReclassificationDescriptionAxis", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_ReclassificationDescriptionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reclassification Description.", "label": "Reclassification Description [Domain]" } } }, "localname": "ReclassificationDescriptionDomain", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_RedemptionPricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption price per warrant.", "label": "Redemption Price Per Warrant", "terseLabel": "Redemption price per warrant" } } }, "localname": "RedemptionPricePerWarrant", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "piai_RelatedPartyNoteTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related party note tranche one.", "label": "Related Party Note Tranche One [Member]" } } }, "localname": "RelatedPartyNoteTrancheOneMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_RemeasurementOnClassaOrdinarySharesSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Remeasurement on class\u00a0A ordinary shares subject to possible redemption.", "label": "Remeasurement On ClassA ordinary Shares Subject To Possible Redemption", "terseLabel": "Remeasurement on Class\u00a0A ordinary shares subject to possible redemption" } } }, "localname": "RemeasurementOnClassaOrdinarySharesSubjectToPossibleRedemption", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "piai_RestrictedInvestmentsTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted investments term.", "label": "Restricted Investments Term", "terseLabel": "Restricted investments term" } } }, "localname": "RestrictedInvestmentsTerm", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "piai_RestrictionOfShareTransferByFoundersPostBusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restriction of share transfer by founders post business combination.", "label": "Restriction Of Share Transfer By Founders Post Business Combination [Member]", "terseLabel": "Restriction Of Share Transfer By Founders Post Business Combination [Member]" } } }, "localname": "RestrictionOfShareTransferByFoundersPostBusinessCombinationMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities to be listed either at the time of business combination or liquidation.", "label": "Securities To Be Listed Either At The Time Of Business Combination Or Liquidation [Member]", "terseLabel": "Securities To Be Listed Either At The Time Of Business Combination Or Liquidation [Member]" } } }, "localname": "SecuritiesToBeListedEitherAtTheTimeOfBusinessCombinationOrLiquidationMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_SharesSubcategoryAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares subcategory [Axis].", "label": "Shares Subcategory [Axis]", "terseLabel": "Shares Subcategory [Axis]" } } }, "localname": "SharesSubcategoryAxis", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "piai_SharesSubcategoryDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares subcategory.", "label": "Shares Subcategory [Domain]", "terseLabel": "Shares Subcategory [Domain]" } } }, "localname": "SharesSubcategoryDomain", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_SponsorsOfficersAndDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsors officers and directors.", "label": "Sponsors Officers And Directors [Member]", "terseLabel": "Sponsors Officers And Directors [Member]" } } }, "localname": "SponsorsOfficersAndDirectorsMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_TemporaryEquityAllocableToPublicWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount allocated to Public Warrants.", "label": "Temporary Equity Allocable To Public Warrants", "negatedLabel": "Amount allocated to Public Warrants" } } }, "localname": "TemporaryEquityAllocableToPublicWarrants", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionSummaryOfOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "monetaryItemType" }, "piai_TemporaryEquityDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity Disclosure.", "label": "Temporary Equity Disclosure [Text Block]", "terseLabel": "Class\u00a0A Ordinary Shares Subject to Possible Redemption" } } }, "localname": "TemporaryEquityDisclosureTextBlock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption" ], "xbrltype": "textBlockItemType" }, "piai_TemporaryEquityGrossProceeds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Temporary Equity Gross Proceeds.", "label": "Temporary Equity Gross Proceeds", "terseLabel": "Gross proceeds" } } }, "localname": "TemporaryEquityGrossProceeds", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionSummaryOfOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "monetaryItemType" }, "piai_TemporaryEquityIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Temporary equity issuance costs.", "label": "Temporary Equity Issuance Costs", "negatedLabel": "Class\u00a0A ordinary shares issuance costs" } } }, "localname": "TemporaryEquityIssuanceCosts", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionSummaryOfOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "monetaryItemType" }, "piai_TemporaryEquityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity [Policy text block].", "label": "Temporary Equity [Policy Text Block]", "terseLabel": "Class\u00a0A Ordinary Shares Subject to Possible Redemption" } } }, "localname": "TemporaryEquityPolicyTextBlock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "piai_TermOfRestrictedInvestments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of restricted investments.", "label": "Term Of Restricted Investments", "terseLabel": "Term of restricted investments" } } }, "localname": "TermOfRestrictedInvestments", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "piai_TimeNeededForConsummationOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time needed for consummation of business combination.", "label": "Time Needed For Consummation Of Business Combination", "terseLabel": "Time needed for consummation of business combination" } } }, "localname": "TimeNeededForConsummationOfBusinessCombination", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "piai_UnderwriterFeePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Underwriter fee payable.", "label": "Underwriter Fee Payable", "terseLabel": "Underwriter fee payable" } } }, "localname": "UnderwriterFeePayable", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "piai_UnderwritingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting Agreement.", "label": "Underwriting Agreement [Member]", "terseLabel": "Underwriting Agreement [Member]" } } }, "localname": "UnderwritingAgreementMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "piai_UnderwritingDiscountPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting discount per share.", "label": "Underwriting Discount Per Share", "terseLabel": "Underwriting discount per share" } } }, "localname": "UnderwritingDiscountPerShare", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "piai_VolumeWeightedAverageTradingPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Volume-weighted average trading price.", "label": "Volume Weighted Average Trading Price", "terseLabel": "Volume-weighted average trading price" } } }, "localname": "VolumeWeightedAverageTradingPrice", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "piai_WarrantLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Liabilities.", "label": "Warrant Liabilities [Member]", "terseLabel": "Warrant Liabilities" } } }, "localname": "WarrantLiabilitiesMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "piai_WeightedAverageNumberOfSharesGrossAmountToForfeitureCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average number of shares gross amount to forfeiture common stock.", "label": "Weighted Average Number Of Shares Gross Amount to forfeiture Common Stock", "terseLabel": "Common stock shares subject to forfeiture" } } }, "localname": "WeightedAverageNumberOfSharesGrossAmountToForfeitureCommonStock", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "piai_WorkingCapitalLoanConvertibleIntoWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital loan convertible into warrants.", "label": "Working Capital Loan Convertible Into Warrants", "terseLabel": "Working capital loan convertible into warrants post business combination" } } }, "localname": "WorkingCapitalLoanConvertibleIntoWarrants", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "piai_WorkingCapitalLoanConvertibleIntoWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working capital loan convertible into warrants.", "label": "Working Capital Loan Convertible Into Warrants [Member]", "terseLabel": "Working Capital Loan Convertible Into Warrants [Member]" } } }, "localname": "WorkingCapitalLoanConvertibleIntoWarrantsMember", "nsuri": "http://www.iposcoop.com/20220331", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r141", "r152", "r186", "r188", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r291", "r292", "r311", "r312" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r141", "r152", "r186", "r188", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r291", "r292", "r311", "r312" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r141", "r152", "r176", "r186", "r188", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r291", "r292", "r311", "r312" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r141", "r152", "r176", "r186", "r188", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r291", "r292", "r311", "r312" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r1", "r59", "r60", "r61", "r62", "r63", "r64", "r65", "r66", "r67", "r69", "r70", "r71", "r72", "r73", "r74", "r87", "r116", "r117", "r197", "r209", "r218", "r219", "r220", "r221", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r321", "r322" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r1", "r59", "r60", "r61", "r62", "r63", "r64", "r65", "r66", "r67", "r69", "r70", "r71", "r72", "r73", "r74", "r87", "r116", "r117", "r197", "r209", "r218", "r219", "r220", "r221", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r321", "r322" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r68", "r74", "r187" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r68", "r74", "r126", "r187", "r254" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities [Member]", "terseLabel": "Accounts Payable and Accrued Liabilities [Member]" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r22", "r251" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r16", "r197", "r251" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional\u00a0paid-in\u00a0capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r59", "r60", "r61", "r194", "r195", "r196", "r219" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r166", "r173" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "verboseLabel": "Adjustment to additional paid in capital stock issuance costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from the computation of earnings per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r57", "r103", "r105", "r109", "r114", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r210", "r212", "r233", "r249", "r251", "r280", "r286" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r9", "r29", "r57", "r114", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r210", "r212", "r233", "r249", "r251" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r222" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Assets, fair value disclosure" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r54" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Investments held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r215", "r216" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BankOverdrafts": { "auth_ref": [ "r24", "r128" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing.", "label": "Bank Overdrafts", "terseLabel": "Working capital loan outstanding" } } }, "localname": "BankOverdrafts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalUnitsMember": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Type of ownership interest in a corporation. Class of capital units or capital shares.", "label": "Capital Units [Member]", "terseLabel": "Capital Units [Member]" } } }, "localname": "CapitalUnitsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_Cash": { "auth_ref": [ "r21", "r251", "r303", "r304" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r21", "r50" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r11", "r51" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r11", "r51", "r279" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Investments\u00a0Held in Trust Account" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r45", "r50", "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash - ending of the period", "periodStartLabel": "Cash - beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "Cash insured" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r55", "r57", "r77", "r78", "r79", "r82", "r84", "r90", "r91", "r92", "r114", "r129", "r133", "r134", "r135", "r138", "r139", "r150", "r151", "r155", "r159", "r233", "r318" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAdditionalInformationDetail", "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CondensedBalanceSheets", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows", "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "http://www.iposcoop.com/role/CondensedStatementsOfOperations", "http://www.iposcoop.com/role/CoverPage", "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r174", "r189" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Class of warrants or rights exercise price per unit of warrant", "verboseLabel": "Warrants exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "verboseLabel": "Number of warrants or rights outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r26", "r125", "r282", "r289" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r122", "r123", "r124", "r127", "r310" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments\u00a0and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Common Class A [Member]", "verboseLabel": "Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAdditionalInformationDetail", "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CondensedBalanceSheets", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "http://www.iposcoop.com/role/CondensedStatementsOfOperations", "http://www.iposcoop.com/role/CoverPage", "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Common Class B [Member]", "verboseLabel": "Class B [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.iposcoop.com/role/CondensedBalanceSheets", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "http://www.iposcoop.com/role/CondensedStatementsOfOperations", "http://www.iposcoop.com/role/CoverPage", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r59", "r60", "r219" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Ordinary Shares [Member]", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAdditionalInformationDetail", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAdditionalInformationDetail", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r166" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common Stock, Shares Subscribed but Unissued", "terseLabel": "Common stock shares issuable" } } }, "localname": "CommonStockSharesSubscribedButUnissued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r15", "r251" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r95", "r285" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostsAndExpensesRelatedParty": { "auth_ref": [ "r37" ], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties.", "label": "Costs and Expenses, Related Party", "terseLabel": "Administrative expenses - related party" } } }, "localname": "CostsAndExpensesRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r140", "r143" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Working capital loan convertible into warrants conversion price per warrant" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Basic and diluted net income (loss) per ordinary share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.iposcoop.com/role/CondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Basic and diluted net income (loss) per ordinary share:" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]" } } }, "localname": "EarningsPerShareBasicLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r85", "r86" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Income Per Ordinary Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r33", "r34", "r35", "r59", "r60", "r61", "r63", "r70", "r73", "r89", "r115", "r166", "r173", "r194", "r195", "r196", "r208", "r209", "r219", "r234", "r235", "r236", "r237", "r238", "r239", "r293", "r294", "r295", "r322" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees": { "auth_ref": [ "r284" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expense related to distribution, servicing and underwriting fees.", "label": "Expense Related to Distribution or Servicing and Underwriting Fees", "terseLabel": "Underwriting expenses", "verboseLabel": "Underwriting discount" } } }, "localname": "ExpenseRelatedToDistributionOrServicingAndUnderwritingFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of the Table Provides Quantitative Information Regarding Level\u00a03 Fair Value Measurements Inputs at their Measurement Dates" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r222", "r223" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Summary of Assets that are Measured at Fair Value on a Recurring Basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r142", "r144", "r145", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r185", "r223", "r256", "r257", "r258" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesDetail", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r228", "r229" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r222", "r223", "r225", "r226", "r230" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r142", "r177", "r178", "r183", "r185", "r223", "r256" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r142", "r144", "r145", "r177", "r178", "r183", "r185", "r223", "r257" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r142", "r144", "r145", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r185", "r223", "r258" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3 [Member]", "verboseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesDetail", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "verboseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r142", "r144", "r145", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r185", "r256", "r257", "r258" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfTheDerivativeWarrantLiabilitiesDetail", "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r228", "r230" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.", "label": "Financial Liabilities Fair Value Disclosure", "terseLabel": "Financial Liabilities Fair Value Disclosure" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Liabilities Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "FinancialLiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r40", "r48", "r112" ], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.iposcoop.com/role/CondensedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "negatedLabel": "Income from investments held in Trust Account", "terseLabel": "Income from investments held in Trust Account" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows", "http://www.iposcoop.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r38" ], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r120", "r121" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r32", "r200", "r201", "r204", "r205", "r206", "r207" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r47" ], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r47" ], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r47" ], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r39", "r102" ], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r23", "r57", "r106", "r114", "r129", "r130", "r131", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r211", "r212", "r213", "r233", "r249", "r250" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r20", "r57", "r114", "r233", "r251", "r281", "r288" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r25", "r57", "r114", "r129", "r130", "r131", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r211", "r212", "r213", "r233", "r249", "r250", "r251" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities": { "auth_ref": [ "r3" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of estimated accrued costs to dispose of assets or other items expected to be sold in liquidation.", "label": "Liquidation Basis of Accounting, Accrued Costs to Dispose of Assets and Liabilities", "terseLabel": "Estimated expenses payable on liquidation" } } }, "localname": "LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinimumNetWorthRequiredForCompliance": { "auth_ref": [ "r306", "r307", "r308", "r309" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum net worth required for mortgage banking as defined by regulatory framework.", "label": "Minimum Net Worth Required for Compliance", "terseLabel": "Minimum net worth needed post business combination" } } }, "localname": "MinimumNetWorthRequiredForCompliance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r45", "r46", "r49" ], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r30", "r31", "r35", "r36", "r49", "r57", "r62", "r64", "r65", "r67", "r68", "r72", "r73", "r80", "r103", "r104", "r107", "r108", "r110", "r114", "r129", "r130", "r131", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r221", "r233", "r283", "r290" ], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.iposcoop.com/role/CondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows", "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "http://www.iposcoop.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r64", "r65", "r67", "r68", "r75", "r76", "r81", "r84", "r103", "r104", "r107", "r108", "r110" ], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Allocation of net income (loss)", "totalLabel": "Net income attributable" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.iposcoop.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpenseMember": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.", "label": "Operating Expense [Member]", "terseLabel": "Operating Expense [Member]" } } }, "localname": "OperatingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r103", "r104", "r107", "r108", "r110" ], "calculation": { "http://www.iposcoop.com/role/CondensedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r4", "r58", "r101", "r214" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "terseLabel": "Description of Organization and Business Operations" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r44" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "verboseLabel": "Payment of stock issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRestrictedInvestments": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.", "label": "Payments to Acquire Restricted Investments", "verboseLabel": "Payments towards restricted investments" } } }, "localname": "PaymentsToAcquireRestrictedInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r14", "r150" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock par or stated value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r14", "r150" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r14", "r251" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r6", "r8", "r118", "r119" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "verboseLabel": "Proceeds from initial public offer" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "verboseLabel": "Proceeds from issue of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "verboseLabel": "Proceeds from related party debt" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.", "label": "Redeemable Noncontrolling Interest, by Legal Entity [Table]" } } }, "localname": "RedeemableNoncontrollingInterestByLegalEntityTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RedeemableNoncontrollingInterestLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Redeemable Noncontrolling Interest [Line Items]" } } }, "localname": "RedeemableNoncontrollingInterestLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r184", "r243", "r244" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r184", "r243", "r244", "r246" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.", "label": "Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party", "terseLabel": "Related party transaction administration and related expenses" } } }, "localname": "RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r184", "r243", "r246", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r241", "r242", "r244", "r247", "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]", "terseLabel": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r17", "r173", "r197", "r251", "r287", "r297", "r302" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r59", "r60", "r61", "r63", "r70", "r73", "r115", "r194", "r195", "r196", "r208", "r209", "r219", "r293", "r295" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock issue price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Basic And Diluted Net Income per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": { "auth_ref": [ "r77", "r78", "r82", "r84", "r88" ], "lang": { "en-us": { "role": { "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.", "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]" } } }, "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r27", "r55", "r90", "r91", "r146", "r148", "r149", "r150", "r151", "r152", "r153", "r155", "r159", "r164", "r167", "r168", "r169", "r170", "r171", "r172", "r173" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.", "label": "Schedule of Subsidiary or Equity Method Investee [Table]" } } }, "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r191" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price", "verboseLabel": "Stock price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r190", "r198" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/FairValueMeasurementsSummaryOfTheTableProvidesQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAtTheirMeasurementDatesDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued, price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, Shares", "periodStartLabel": "Beginning Balance, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r53", "r58" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "Basis of Presentation and Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r13", "r14", "r15", "r55", "r57", "r77", "r78", "r79", "r82", "r84", "r90", "r91", "r92", "r114", "r129", "r133", "r134", "r135", "r138", "r139", "r150", "r151", "r155", "r159", "r166", "r233", "r318" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAdditionalInformationDetail", "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CondensedBalanceSheets", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows", "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "http://www.iposcoop.com/role/CondensedStatementsOfOperations", "http://www.iposcoop.com/role/CoverPage", "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r28", "r33", "r34", "r35", "r59", "r60", "r61", "r63", "r70", "r73", "r89", "r115", "r166", "r173", "r194", "r195", "r196", "r208", "r209", "r219", "r234", "r235", "r236", "r237", "r238", "r239", "r293", "r294", "r295", "r322" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows", "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "http://www.iposcoop.com/role/CondensedStatementsOfOperations", "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r59", "r60", "r61", "r89", "r266" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows", "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit", "http://www.iposcoop.com/role/CondensedStatementsOfOperations", "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "verboseLabel": "Stock shares issued during the period shares for services rendered" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r14", "r15", "r166", "r173" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "verboseLabel": "Stock shares issued during the period during new issues shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited", "terseLabel": "Ordinary shares forfeited" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "verboseLabel": "Stock shares issued during the period value for services rendered" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r15", "r18", "r19", "r57", "r111", "r114", "r233", "r251" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total Shareholders' Deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets", "http://www.iposcoop.com/role/CondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r56", "r151", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r165", "r173", "r175" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Shareholders' Deficit" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/ShareholdersDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r240", "r253" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r240", "r253" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r252", "r255" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.iposcoop.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.iposcoop.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.iposcoop.com/role/ShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental disclosure of noncash investing and financing activities:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "terseLabel": "Accretion of carrying value to redemption value" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionSummaryOfOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r129", "r133", "r134", "r135", "r138", "r139" ], "calculation": { "http://www.iposcoop.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "presentationGuidance": "Class\u00a0A ordinary shares subject to possible redemption", "terseLabel": "Class A ordinary shares subject to possible redemption, $0.0001 par value; 32,408,414 shares issued and outstanding at $10.00 per share at redemption as of March 31, 2022 and December 31, 2021" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionSummaryOfOrdinarySharesSubjectToPossibleRedemptionDetail", "http://www.iposcoop.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Temporary Equity Disclosure [Abstract]" } } }, "localname": "TemporaryEquityDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r10", "r147" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Temporary equity redemption value per share" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r10", "r147" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Temporary equity redemption price per share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical", "http://www.iposcoop.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary equity shares issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Temporary equity shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAdditionalInformationDetail", "http://www.iposcoop.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquityTableTextBlock": { "auth_ref": [ "r10", "r147" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity [Table Text Block]", "terseLabel": "Schedule of Class A Ordinary Shares Subject to Possible Redemption" } } }, "localname": "TemporaryEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r199", "r203" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized income tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r202" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Unrecognized income tax benefits accrued interest and penalty" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r93", "r94", "r96", "r97", "r98", "r99", "r100" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrants and rights outstanding, term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "positiveLabel": "Basic and diluted weighted average ordinary shares outstanding", "terseLabel": "Weighted average ordinary shares outstanding, basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.iposcoop.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomePerShareDetail", "http://www.iposcoop.com/role/CondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r101": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r124": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r127": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r255": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.14)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=95464943&loc=SL35686261-199414" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47080-110998" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r313": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r314": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r315": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r316": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r317": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r318": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r319": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r320": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" } }, "version": "2.1" } ZIP 54 0001193125-22-151154-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-151154-xbrl.zip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end